https://drug.russellpublishing.co.uk/article/50/imi-update-k4dd-kinetics-drug-discovery/2017-11-08T16:54:52+00:00https://drug.russellpublishing.co.uk/article/52/day-life-kenji-schorpp-assay-development-screening-scientist/2017-01-17T16:53:39+00:00https://drug.russellpublishing.co.uk/article/55/day-life-justin-bryans/2017-09-26T09:58:37+01:00https://drug.russellpublishing.co.uk/article/62/collaborative-drug-discovery-update-progress-initiatives/2017-01-16T15:06:26+00:00https://drug.russellpublishing.co.uk/article/791/genomics-in-depth-focus-2014/2016-12-13T17:52:24+00:00https://drug.russellpublishing.co.uk/article/818/foreword-enabling-the-development-of-new-medicines/2019-01-23T10:29:53+00:00https://drug.russellpublishing.co.uk/article/821/molecular-target-validation-in-preclinical-drug-discovery/2018-10-11T09:40:31+01:00https://drug.russellpublishing.co.uk/article/824/nuclear-magnetic-resonance-as-a-tool-for-chemokine-inhibitor-discovery/2019-01-23T12:33:38+00:00https://drug.russellpublishing.co.uk/article/826/marine-drug-discovery-realising-the-potential-of-therapeutics-from-marine-sources/2019-01-23T12:44:55+00:00https://drug.russellpublishing.co.uk/article/830/building-gpcr-screening-cascades-for-lead-generation/2019-01-23T13:01:30+00:00https://drug.russellpublishing.co.uk/article/835/oncology-biomarkers-in-clinical-practice/2019-01-23T12:50:58+00:00https://drug.russellpublishing.co.uk/article/837/academia-big-pharma-collaboration-in-drug-development/2019-01-23T12:55:43+00:00https://drug.russellpublishing.co.uk/article/1066/drug-target-review-issue-1-2014/2016-12-13T12:29:44+00:00https://drug.russellpublishing.co.uk/article/1194/screening-in-depth-focus-2014/2016-12-13T17:55:22+00:00https://drug.russellpublishing.co.uk/article/1463/lab-robotics-and-automation/2017-09-13T17:07:38+01:00https://drug.russellpublishing.co.uk/article/1802/antibody-discovery-technologies/2017-01-16T13:31:46+00:00https://drug.russellpublishing.co.uk/article/1850/synthetic-macrocyclic-receptors/2017-01-16T12:29:52+00:00https://drug.russellpublishing.co.uk/article/1885/neutrons-homing-targeted-drug-delivery/2017-01-16T12:26:29+00:00https://drug.russellpublishing.co.uk/article/1904/formation-nano-micro-scale-drug-delivery-systems-using-microfluidic-technology/2017-01-16T12:16:33+00:00https://drug.russellpublishing.co.uk/article/2845/meet-the-editorial-board-members-who-influenced-the-spring-2015-issue/2016-12-22T14:09:41+00:00https://drug.russellpublishing.co.uk/article/3271/drug-target-review-issue-1-2015/2017-01-23T09:54:05+00:00https://drug.russellpublishing.co.uk/article/3293/drug-targets-in-depth-focus-2015/2016-12-13T17:48:00+00:00https://drug.russellpublishing.co.uk/article/3335/ngs-in-depth-focus-2015/2016-12-13T17:44:38+00:00https://drug.russellpublishing.co.uk/article/3346/human-induced-pluripotent-stem-cells-for-liver-disease-and-toxicology/2018-09-28T16:44:27+01:00https://drug.russellpublishing.co.uk/article/3352/the-quest-for-accurate-target-validation-2/2016-12-22T13:58:36+00:00https://drug.russellpublishing.co.uk/article/3355/evaluation-of-a-gadd45a-gfp-human-cell-assay-for-rapid-and-reliable-in-vitro-early-genotoxicity-screening-2/2018-09-28T16:26:34+01:00https://drug.russellpublishing.co.uk/article/3357/label-free-technologies-for-biomolecular-interaction-monitoring-2/2018-09-28T16:14:58+01:00https://drug.russellpublishing.co.uk/article/3361/the-impact-of-phenotypic-and-functional-screening-in-cns-drug-discovery-2/2018-09-28T16:09:49+01:00https://drug.russellpublishing.co.uk/article/3370/academic-high-throughput-screening-opportunities-for-change/2018-09-28T16:16:42+01:00https://drug.russellpublishing.co.uk/article/3425/workshop-review-cell-based-assays-for-screening-december-2014/2018-08-06T15:54:32+01:00https://drug.russellpublishing.co.uk/article/4533/novel-approaches-to-targeting-protein-tyrosine-kinases/2018-12-05T09:25:26+00:00https://drug.russellpublishing.co.uk/article/4540/developing-antibody-therapeutics/2018-12-05T09:01:43+00:00https://drug.russellpublishing.co.uk/article/4602/from-hype-to-hope-challenging-the-norm-in-lead-discovery/2018-12-05T08:50:00+00:00https://drug.russellpublishing.co.uk/article/4605/a-new-dawn-in-academic-and-pharma-collaboration-a-uk-perspective/2018-12-05T08:45:26+00:00https://drug.russellpublishing.co.uk/article/4613/true-screening-for-immunology-transforming-science-with-a-practical-tool-for-large-scale-discovery/2019-01-17T10:15:30+00:00https://drug.russellpublishing.co.uk/article/4617/academic-drug-discovery-in-neurodegeneration-a-new-approach-to-an-ageing-problem/2018-12-05T08:21:15+00:00https://drug.russellpublishing.co.uk/article/4624/drug-target-review-issue-2-2015/2016-12-13T12:22:22+00:00https://drug.russellpublishing.co.uk/article/4646/screening-in-depth-focus-2015/2016-12-13T17:42:04+00:00https://drug.russellpublishing.co.uk/article/4656/stem-cells-in-depth-focus-2015/2016-12-13T17:39:36+00:00https://drug.russellpublishing.co.uk/article/4772/product-hub-molecular-devices/2017-06-07T16:22:41+01:00https://drug.russellpublishing.co.uk/article/5063/stem-cells-maintaining-hope-and-challenging-hype/2017-09-13T17:07:37+01:00https://drug.russellpublishing.co.uk/article/5634/sspc-advancing-science-from-molecule-to-medicine/2018-03-19T14:13:55+00:00https://drug.russellpublishing.co.uk/article/6316/proteomics-in-depth-focus-2015/2016-12-21T08:20:24+00:00https://drug.russellpublishing.co.uk/article/6324/imaging-in-depth-focus-2015/2016-12-21T08:43:24+00:00https://drug.russellpublishing.co.uk/article/6330/drug-target-review-issue-3-2015/2016-12-13T11:39:20+00:00https://drug.russellpublishing.co.uk/article/6336/enzymes-ubiquitin-specific-proteases-as-druggable-targets/2018-12-10T09:38:41+00:00https://drug.russellpublishing.co.uk/article/6339/flow-cytometry-not-just-a-box-in-the-lab/2018-12-06T08:57:22+00:00https://drug.russellpublishing.co.uk/article/6342/exploiting-functional-selectivity-of-gpcrs-in-drug-development/2018-12-06T08:51:15+00:00https://drug.russellpublishing.co.uk/article/6347/ion-channels-small-molecules-versus-biologics-the-quest-for-the-ideal-nav1-7-inhibitor/2018-12-06T08:41:10+00:00https://drug.russellpublishing.co.uk/article/6353/microfluidic-technology-the-next-generation-drug-discovery-tool/2018-12-06T08:33:31+00:00https://drug.russellpublishing.co.uk/article/6356/immunogenicity-anticipating-and-avoiding-issues-for-biopharmaceutical-development/2018-12-06T08:28:04+00:00https://drug.russellpublishing.co.uk/article/6425/when-0-77-is-greater-than-1-salutatory-lessons-from-the-court-of-appeal/2018-12-06T08:19:33+00:00https://drug.russellpublishing.co.uk/article/6927/the-importance-of-measuring-drug-target-residence-times/2017-01-19T11:13:35+00:00https://drug.russellpublishing.co.uk/article/6937/somascan-assay-a-vital-proteomic-tool-in-drug-discovery/2017-01-11T12:07:02+00:00https://drug.russellpublishing.co.uk/article/8014/drug-target-review-issue-4-2015/2016-12-13T11:34:18+00:00https://drug.russellpublishing.co.uk/article/8056/companion-diagnostics-challenges-in-the-development-of-pharmacistbased-point-of-care-tests/2018-12-10T10:55:13+00:00https://drug.russellpublishing.co.uk/article/8059/protein-expression-the-growing-potential-of-plant-made-monoclonal-antibodies/2018-12-10T10:50:47+00:00https://drug.russellpublishing.co.uk/article/8068/next-generation-transcriptomic-analysis-in-cancer-vascular-research/2018-12-10T10:28:14+00:00https://drug.russellpublishing.co.uk/article/8071/3d-printing-a-new-era-for-personalised-medicines/2018-12-10T10:19:56+00:00https://drug.russellpublishing.co.uk/article/8077/enabling-new-targets-by-integrated-lead-discovery/2018-12-10T10:09:57+00:00https://drug.russellpublishing.co.uk/article/8081/the-challenges-associated-with-de-risking-earlystage-therapeutic-targets/2018-12-10T10:01:31+00:00https://drug.russellpublishing.co.uk/article/8086/biomarkers-as-molecular-footprints-for-cancer-therapy-current-perspectives-and-promises/2018-12-10T09:51:20+00:00https://drug.russellpublishing.co.uk/article/8089/foreword-health-and-safety-law/2018-12-10T09:42:15+00:00https://drug.russellpublishing.co.uk/article/8144/mass-spectrometry-in-depth-focus-2015/2016-12-20T09:18:03+00:00https://drug.russellpublishing.co.uk/article/9722/drug-target-reviews-top-10-stories-from-2015/2017-09-13T17:07:36+01:00https://drug.russellpublishing.co.uk/article/9857/zika-virus-a-public-emergency-of-international-concern/2020-03-24T15:10:30+00:00https://drug.russellpublishing.co.uk/article/9973/cansar-a-portal-to-big-data-for-drug-discovery/2017-09-13T16:59:22+01:00https://drug.russellpublishing.co.uk/article/10037/wanted-zika-virus-researchers/2018-01-08T14:53:18+00:00https://drug.russellpublishing.co.uk/article/10432/directing-a-weaponised-attack-on-cancer-with-natural-killer-receptor-t-cells/2017-09-13T16:59:20+01:00https://drug.russellpublishing.co.uk/article/10534/the-case-for-data-analytics-in-proof-of-concept-studies/2017-09-13T16:59:20+01:00https://drug.russellpublishing.co.uk/article/10774/browsing-for-drug-targets/2021-03-25T10:43:04+00:00https://drug.russellpublishing.co.uk/article/10914/uk-life-sciences-stronger-eu-bia/2017-09-13T16:59:18+01:00https://drug.russellpublishing.co.uk/article/10942/drug-target-review-issue-1-2016/2016-12-13T11:12:01+00:00https://drug.russellpublishing.co.uk/article/10951/drug-targets-in-depth-focus-2016/2016-12-13T17:28:55+00:00https://drug.russellpublishing.co.uk/article/10960/assays-in-depth-focus-2016/2017-09-26T09:54:02+01:00https://drug.russellpublishing.co.uk/article/10969/antibodies-in-depth-focus-2016/2016-12-19T20:42:30+00:00https://drug.russellpublishing.co.uk/article/10980/classifying-brain-tumours-improve-diagnoses/2018-08-15T16:52:53+01:00https://drug.russellpublishing.co.uk/article/10985/strategies-identifying-predictive-biomarkers-non-alcoholic-fatty-liver-disease/2018-08-15T16:58:21+01:00https://drug.russellpublishing.co.uk/article/10990/pushing-limits-protein-expression-mirnas/2018-08-15T17:02:42+01:00https://drug.russellpublishing.co.uk/article/10999/microfluidics-fur-free-way-towards-personalised-medicine-cancer-therapy/2018-08-15T17:07:10+01:00https://drug.russellpublishing.co.uk/article/11002/using-computational-models-aid-drug-discovery/2019-01-23T10:13:53+00:00https://drug.russellpublishing.co.uk/article/11013/interview-amrik-basran-chief-scientific-officer-avacta-life-sciences/2018-08-15T17:09:31+01:00https://drug.russellpublishing.co.uk/article/11066/explaining-car-t-cell-therapy/2017-09-13T16:59:18+01:00https://drug.russellpublishing.co.uk/article/11216/eu-referendum-poll/2017-09-13T16:59:17+01:00https://drug.russellpublishing.co.uk/article/11368/drug-discovery-drug-target-review/2017-09-13T16:59:16+01:00https://drug.russellpublishing.co.uk/article/11525/threat-antibiotics-resistance/2017-09-13T16:59:15+01:00https://drug.russellpublishing.co.uk/article/11590/automation-technology/2017-09-13T16:59:16+01:00https://drug.russellpublishing.co.uk/article/11644/advancing-flip-inhibitors/2017-09-13T16:59:15+01:00https://drug.russellpublishing.co.uk/article/11809/soligenix-idr-technology-sgx942/2017-09-13T16:59:14+01:00https://drug.russellpublishing.co.uk/article/11888/pim-flt3-dual-inhibition/2017-09-13T16:59:13+01:00https://drug.russellpublishing.co.uk/article/12064/johnson-johnson-jlinx/2017-09-13T16:59:13+01:00https://drug.russellpublishing.co.uk/article/12188/leaving-eu-bayer/2017-09-13T16:59:12+01:00https://drug.russellpublishing.co.uk/article/12247/drug-target-review-issue-2-2016/2016-12-13T11:04:35+00:00https://drug.russellpublishing.co.uk/article/12260/interview-joseph-jammal-coo-cisbio-bioassays/2018-08-15T16:19:06+01:00https://drug.russellpublishing.co.uk/article/12263/inhibition-rna-containing-viruses-artificial-rnases/2018-11-14T16:31:16+00:00https://drug.russellpublishing.co.uk/article/12269/new-horizons-next-generation-small-molecule-kinase-inhibitors/2018-11-14T14:31:18+00:00https://drug.russellpublishing.co.uk/article/12274/rare-diseases-qa/2019-01-31T15:40:16+00:00https://drug.russellpublishing.co.uk/article/12291/advanced-techniques-applications-lc-ms-small-molecule-drug-discovery/2018-08-15T16:45:56+01:00https://drug.russellpublishing.co.uk/article/12297/organs-on-chips-gearing-up-to-disrupt-the-microbiome-market/2018-08-15T16:48:37+01:00https://drug.russellpublishing.co.uk/article/12312/modulating-the-microbiome/2017-09-13T16:59:12+01:00https://drug.russellpublishing.co.uk/article/12315/stem-cells-in-depth-focus-2016/2017-09-26T09:49:05+01:00https://drug.russellpublishing.co.uk/article/12327/omics-in-depth-focus-2016/2016-12-19T19:07:08+00:00https://drug.russellpublishing.co.uk/article/12456/theravance-vibativ-antibiotic-resistance/2017-09-13T16:59:11+01:00https://drug.russellpublishing.co.uk/article/12470/eu-referendum-tell-us-think/2017-09-13T16:59:11+01:00https://drug.russellpublishing.co.uk/article/12931/lyme-disease-caudwell/2017-09-13T16:59:10+01:00https://drug.russellpublishing.co.uk/article/12998/30-million-fund-research-hiv-cure/2017-09-13T16:59:09+01:00https://drug.russellpublishing.co.uk/article/13132/moderna-mrna-therapeutics/2017-09-13T16:59:09+01:00https://drug.russellpublishing.co.uk/article/13714/pokemon-go-diabetes/2017-09-13T16:59:08+01:00https://drug.russellpublishing.co.uk/article/13839/medicalising-marijuana-treatment/2017-09-13T16:59:08+01:00https://drug.russellpublishing.co.uk/article/14116/drug-target-review-issue-3-2016/2016-12-20T22:30:32+00:00https://drug.russellpublishing.co.uk/article/14197/imaging-in-depth-focus-2016/2016-12-13T16:32:46+00:00https://drug.russellpublishing.co.uk/article/14205/hit-to-lead-in-depth-focus-2016/2016-12-13T16:28:35+00:00https://drug.russellpublishing.co.uk/article/14237/vigilin-heart-attack-fatty-liver/2017-09-13T16:59:07+01:00https://drug.russellpublishing.co.uk/article/14249/fibromyalgia-pathogenesis-target/2017-11-05T15:53:54+00:00https://drug.russellpublishing.co.uk/article/14272/high-throughput-calcium-flux-assays-luminescent-versus-fluorescent-readout/2017-11-05T16:00:31+00:00https://drug.russellpublishing.co.uk/article/14324/switching-genes-regulating-oxysterol-synthesis-therapeutic-option/2017-11-05T16:04:57+00:00https://drug.russellpublishing.co.uk/article/14500/basel-life-science-week-lab/2017-09-13T16:59:07+01:00https://drug.russellpublishing.co.uk/article/14512/flow-cytometry-breaking-bottlenecks-drug-discovery-development/2017-11-05T16:10:10+00:00https://drug.russellpublishing.co.uk/article/14628/ivf-designer-babies-easy-1-23/2017-09-13T16:59:05+01:00https://drug.russellpublishing.co.uk/article/14632/poverty-cancer-appalachia/2017-09-13T16:59:06+01:00https://drug.russellpublishing.co.uk/article/14746/nanoscience-health-lives/2017-09-13T16:59:06+01:00https://drug.russellpublishing.co.uk/article/14870/microscope-dr-jeffrey-borgia-rush-medical-center/2017-11-05T16:11:59+00:00https://drug.russellpublishing.co.uk/article/14873/microscope-joseph-zock-intellicyt-corporation/2019-01-17T10:16:04+00:00https://drug.russellpublishing.co.uk/article/14877/product-hub-end-to-end-next-generation-sequencing/2016-12-19T18:51:55+00:00https://drug.russellpublishing.co.uk/article/14948/multiple-sclerosis-hervs/2017-09-13T16:59:05+01:00https://drug.russellpublishing.co.uk/article/15037/a-is-for-alzheimers-disease/2017-09-13T16:59:04+01:00https://drug.russellpublishing.co.uk/article/15053/b-is-for-biomarkers/2017-09-13T16:59:04+01:00https://drug.russellpublishing.co.uk/article/15059/c-is-for-crispr/2017-09-13T16:59:03+01:00https://drug.russellpublishing.co.uk/article/15088/d-is-for-diabetes/2017-09-13T16:59:03+01:00https://drug.russellpublishing.co.uk/article/15230/rahul-kapur-research-scientist/2017-09-13T16:59:02+01:00https://drug.russellpublishing.co.uk/article/15400/artificial-intelligence-drug-discovery/2017-09-13T16:59:01+01:00https://drug.russellpublishing.co.uk/article/15438/next-generation-sequencing-depth-focus-2016/2016-12-14T16:30:24+00:00https://drug.russellpublishing.co.uk/article/15439/personalised-medicines-in-depth-focus-2016/2016-12-16T14:48:31+00:00https://drug.russellpublishing.co.uk/article/15440/screening-in-depth-focus-2016/2017-01-10T09:56:04+00:00https://drug.russellpublishing.co.uk/article/17536/drug-target-review-issue-4-2016/2017-03-19T19:49:30+00:00https://drug.russellpublishing.co.uk/article/18005/exploring-the-need-for-mutation-specific-treatments-in-cystic-fibrosis/2018-07-04T10:51:23+01:00https://drug.russellpublishing.co.uk/article/18013/pathogens-in-transport/2017-11-05T15:13:11+00:00https://drug.russellpublishing.co.uk/article/18022/translational-proteomics/2017-11-05T15:17:07+00:00https://drug.russellpublishing.co.uk/article/18090/antagonists-targeting-ion-channels/2017-11-05T15:21:54+00:00https://drug.russellpublishing.co.uk/article/18640/industrialising-organoids/2017-09-13T16:59:01+01:00https://drug.russellpublishing.co.uk/article/20864/draper-mps-technology/2017-09-26T09:27:44+01:00https://drug.russellpublishing.co.uk/article/21644/ketamine-depression/2017-09-13T16:58:58+01:00https://drug.russellpublishing.co.uk/article/21681/genomics-protecting-data-privacy/2017-09-13T16:58:58+01:00https://drug.russellpublishing.co.uk/article/21913/product-hub-flow-cytometric-screening-assays-drug-discovery/2017-11-05T15:24:05+00:00https://drug.russellpublishing.co.uk/article/21932/potential-hips-derived-beta-cells/2017-11-05T15:25:04+00:00https://drug.russellpublishing.co.uk/article/22178/drug-target-review-issue-1-2017/2017-06-02T11:47:41+01:00https://drug.russellpublishing.co.uk/article/22207/antibodies-in-depth-focus-2017/2017-03-19T19:30:24+00:00https://drug.russellpublishing.co.uk/article/22211/assays-in-depth-focus-2017/2017-03-16T15:35:52+00:00https://drug.russellpublishing.co.uk/article/22215/biomarkers-in-depth-focus-2017/2017-03-15T09:20:32+00:00https://drug.russellpublishing.co.uk/article/22273/turning-rare-diseases-ai/2017-09-13T16:58:57+01:00https://drug.russellpublishing.co.uk/article/22289/nanoparticle-mediated-enzyme-delivery-application-cancer-therapy/2017-11-05T17:36:06+00:00https://drug.russellpublishing.co.uk/article/22309/targeting-gas6-cancer-fibrosis-viral-infection/2017-11-05T17:36:39+00:00https://drug.russellpublishing.co.uk/article/22326/qa-lou-matis-bispecific-antibodies/2017-11-03T15:41:14+00:00https://drug.russellpublishing.co.uk/article/22353/under-the-microscope-with-labcyte/2017-12-06T14:03:46+00:00https://drug.russellpublishing.co.uk/article/22430/deadly-bite-antivenom-shortage/2017-09-13T16:58:57+01:00https://drug.russellpublishing.co.uk/article/22525/edo-model-fast-tracking/2017-09-13T16:58:56+01:00https://drug.russellpublishing.co.uk/article/22631/fluorescence-gsk-expert/2017-10-27T15:20:04+01:00https://drug.russellpublishing.co.uk/article/22795/organ-drug-test/2017-09-13T16:58:55+01:00https://drug.russellpublishing.co.uk/article/22881/creating-google-earth-tumours/2017-09-13T16:58:54+01:00https://drug.russellpublishing.co.uk/article/23168/3d-bioprinting-science-fiction-reality/2017-11-03T15:46:24+00:00https://drug.russellpublishing.co.uk/article/23594/drug-target-review-issue-2-2017/2017-09-06T09:59:48+01:00https://drug.russellpublishing.co.uk/article/23608/screening-in-depth-focus-2017/2017-06-05T08:56:26+01:00https://drug.russellpublishing.co.uk/article/23616/stem-cells-in-depth-focus-2017/2017-08-23T17:35:07+01:00https://drug.russellpublishing.co.uk/article/23624/targets-depth-focus-2017/2017-07-07T09:10:06+01:00https://drug.russellpublishing.co.uk/article/23631/biomarkers-personalised-therapy-cancer/2017-11-05T17:31:51+00:00https://drug.russellpublishing.co.uk/article/23641/native-mass-spectrometry-drug-discovery/2017-11-05T17:32:20+00:00https://drug.russellpublishing.co.uk/article/23683/therapeutics-alzheimers-disease/2017-11-05T17:32:47+00:00https://drug.russellpublishing.co.uk/article/23882/reactive-oxygen-species-ros-homeostasis/2017-09-26T09:45:58+01:00https://drug.russellpublishing.co.uk/article/23902/qa-role-disease-focused-foundations-bridging-drug-discovery-development-gap/2017-09-26T09:26:58+01:00https://drug.russellpublishing.co.uk/article/24121/intracellular-target-validation-cellular-systems-using-peptides/2019-01-31T12:00:35+00:00https://drug.russellpublishing.co.uk/article/24126/new-drug-targets-chlamydia-crispr/2017-11-05T17:33:28+00:00https://drug.russellpublishing.co.uk/article/24145/venoms-uncover-targets-drug-discovery/2017-11-05T17:34:01+00:00https://drug.russellpublishing.co.uk/article/24155/david-f-fischer-target-screening/2019-01-31T12:04:47+00:00https://drug.russellpublishing.co.uk/article/24649/crispr-repairs-genetic-embryos/2017-09-13T16:58:52+01:00https://drug.russellpublishing.co.uk/article/25324/calcilytics-treatments-alzheimers/2018-03-15T10:32:44+00:00https://drug.russellpublishing.co.uk/article/25362/expert-view-effective-coupling-assays-cell-models/2018-03-15T10:31:58+00:00https://drug.russellpublishing.co.uk/article/25369/drug-target-review-issue-3-2017/2021-08-26T11:00:32+01:00https://drug.russellpublishing.co.uk/article/25406/bridging-gap-users-needs/2018-03-15T10:31:35+00:00https://drug.russellpublishing.co.uk/article/25412/assays-in-depth-focus-issue-3-2017/2017-09-18T09:37:13+01:00https://drug.russellpublishing.co.uk/article/25413/expert-view-future-single-cell-sequencing/2018-03-15T10:24:22+00:00https://drug.russellpublishing.co.uk/article/25417/expert-view-overcoming-ngs-obstacles/2018-03-15T10:23:55+00:00https://drug.russellpublishing.co.uk/article/25421/expert-view-single-cell-sequencing-basic-research-clinical-applications/2018-03-15T10:23:05+00:00https://drug.russellpublishing.co.uk/article/25429/expert-view-advances-ngs-technology/2018-03-15T09:54:30+00:00https://drug.russellpublishing.co.uk/article/25430/imaging-depth-focus-issue-3-2017/2017-10-13T13:38:20+01:00https://drug.russellpublishing.co.uk/article/25435/expert-view-technological-breakthrough-flow-cytometry/2017-10-10T11:37:04+01:00https://drug.russellpublishing.co.uk/article/25451/next-generation-sequencing/2017-09-15T09:09:43+01:00https://drug.russellpublishing.co.uk/article/25495/structure-drug-discovery-crystallography/2019-01-31T11:56:09+00:00https://drug.russellpublishing.co.uk/article/25549/assay-image-based-high-content-screening/2019-01-31T11:58:08+00:00https://drug.russellpublishing.co.uk/article/25563/mass-spectrometry-imaging-in-drug-discovery/2019-01-31T11:54:31+00:00https://drug.russellpublishing.co.uk/article/25619/visualising-effects-targeted-therapies-tumours/2019-01-31T11:54:19+00:00https://drug.russellpublishing.co.uk/article/25646/ngs-empowering-infectious-disease-research-beyond-reality/2019-01-22T11:48:13+00:00https://drug.russellpublishing.co.uk/article/25719/next-generation-sequencing-drug-discovery/2019-01-31T11:47:15+00:00https://drug.russellpublishing.co.uk/article/25840/eutcd-grade-lines-an-innovative-approach-to-creating-and-supplying-clinical-hesc-lines/2018-03-15T09:52:15+00:00https://drug.russellpublishing.co.uk/article/25927/expert-view/2017-09-15T15:25:40+01:00https://drug.russellpublishing.co.uk/article/25961/flow-cytometry-accelerating-neuroscience-research/2018-04-26T12:06:33+01:00https://drug.russellpublishing.co.uk/article/26972/drug-patents-expire/2017-12-07T17:08:57+00:00https://drug.russellpublishing.co.uk/article/27871/drug-target-review-issue-4-2017/2018-03-14T15:55:23+00:00https://drug.russellpublishing.co.uk/article/27884/clinically-oriented-phenotypic-screening/2018-06-04T16:42:35+01:00https://drug.russellpublishing.co.uk/article/27895/3-d-bioprinted-tissues-disease-dish-models-drug-screening/2018-06-04T16:42:08+01:00https://drug.russellpublishing.co.uk/article/27913/hit-validation-high-throughput-screening/2018-06-04T16:41:03+01:00https://drug.russellpublishing.co.uk/article/27919/identification-african-trypanosomiasis/2018-06-04T16:35:17+01:00https://drug.russellpublishing.co.uk/article/27923/hit-lead-depth-focus-2017/2018-01-11T16:53:08+00:00https://drug.russellpublishing.co.uk/article/27940/using-bioinformatics-sequence-similarities-optimise-repurposing-activities/2018-06-04T16:38:22+01:00https://drug.russellpublishing.co.uk/article/27950/informatics-depth-focus-2017/2017-12-06T14:35:07+00:00https://drug.russellpublishing.co.uk/article/27987/screening-depth-focus-2017/2017-12-06T15:09:01+00:00https://drug.russellpublishing.co.uk/article/28018/informatics-collaborations/2018-06-04T16:37:12+01:00https://drug.russellpublishing.co.uk/article/28032/machine-learning-approaches-tools-accelerate-drug-discovery/2019-01-22T11:34:58+00:00https://drug.russellpublishing.co.uk/article/28044/patient-derived-neural-progenitor-cells-drug-discovery-model-mitochondrial-diseases/2018-06-04T16:37:43+01:00https://drug.russellpublishing.co.uk/article/28058/proteogenomics-research-frontier-precision-medicine/2018-06-04T16:34:04+01:00https://drug.russellpublishing.co.uk/article/28060/expert-view-addressing-big-challenges-drug-screening/2019-01-17T10:16:29+00:00https://drug.russellpublishing.co.uk/article/28068/expert-view-improving-hit-lead-results/2017-12-07T14:30:52+00:00https://drug.russellpublishing.co.uk/article/28077/expert-view-optimising-hit-lead-workflow/2017-12-07T14:42:11+00:00https://drug.russellpublishing.co.uk/article/28081/expert-view-conquering-late-stage-failures-advanced-hit-lead-techniques/2017-12-14T10:53:18+00:00https://drug.russellpublishing.co.uk/article/28085/qa-implementing-adcc-assays-qc-donor-variability-isnt-option/2021-08-26T11:00:10+01:00https://drug.russellpublishing.co.uk/article/28089/qa-integrated-drug-discovery-panel-questions-answered/2018-07-09T15:29:17+01:00https://drug.russellpublishing.co.uk/article/28118/meeting-access-challenges-adaptive-trial-designs/2017-12-11T09:35:06+00:00https://drug.russellpublishing.co.uk/article/28241/artificial-intelligence-drug-discovery-2/2018-06-04T16:33:28+01:00https://drug.russellpublishing.co.uk/article/28498/rational-drug-design/2018-01-04T16:02:04+00:00https://drug.russellpublishing.co.uk/article/29023/development-design-manufacturing-patient-specific-cell-therapies/2018-01-22T11:12:21+00:00https://drug.russellpublishing.co.uk/article/29106/phenotypic-target-based-screening/2018-01-29T16:31:22+00:00https://drug.russellpublishing.co.uk/article/29495/drug-resistance-kill-cancer-cells/2018-02-22T15:36:06+00:00https://drug.russellpublishing.co.uk/article/29694/biomarkers-herbal-anti-arthritic/2018-02-22T15:48:04+00:00https://drug.russellpublishing.co.uk/article/30440/drug-target-review-issue-1-2018/2018-06-08T08:45:58+01:00https://drug.russellpublishing.co.uk/article/30448/assays-in-depth-focus-2018/2018-03-14T16:03:04+00:00https://drug.russellpublishing.co.uk/article/30461/informatics-in-depth-focus-2018/2018-06-11T14:30:11+01:00https://drug.russellpublishing.co.uk/article/30467/lab-automation-in-depth-focus-2018/2018-06-11T14:29:35+01:00https://drug.russellpublishing.co.uk/article/30585/expert-view-screening-tools-for-better-lead-characterisation/2018-03-19T12:22:01+00:00https://drug.russellpublishing.co.uk/article/30591/expert-view-toward-physiological-relevance-in-drug-discovery-and-development/2018-03-19T12:37:51+00:00https://drug.russellpublishing.co.uk/article/30594/streamlining-drug-discovery-assays-for-cancer-and-cardiovascular-disease/2018-03-19T13:06:45+00:00https://drug.russellpublishing.co.uk/article/30599/high-throughput-flow-cytometry-for-multifactorial-evaluation-of-novel-therapeutic-candidates-using-an-innovative-in-vitro-immunooncology-screening-platform/2019-01-17T10:22:48+00:00https://drug.russellpublishing.co.uk/article/30607/expert-view-laboratory-informatics-software-the-top-challenges/2018-03-19T16:06:31+00:00https://drug.russellpublishing.co.uk/article/30626/under-the-microscope-choosing-the-best-microplate-reader/2018-03-19T16:57:12+00:00https://drug.russellpublishing.co.uk/article/30685/expert-view-how-ngs-is-continuing-to-revolutionise-our-understanding-of-genomics/2018-03-21T15:33:07+00:00https://drug.russellpublishing.co.uk/article/30690/expert-view-addressing-the-big-challenges-in-cell-based-assays/2018-03-21T15:45:37+00:00https://drug.russellpublishing.co.uk/article/30921/lymphocytes-armed-to-kill-how-customised-cell-engineering-advances-immunotherapy/2018-04-04T11:16:32+01:00https://drug.russellpublishing.co.uk/article/31070/how-the-study-of-lipidomics-is-benefiting-from-recent-advances-in-mass-spectrometry/2018-04-10T11:58:22+01:00https://drug.russellpublishing.co.uk/article/31446/high-throughput-screening-capable-assays-in-3d/2020-01-07T16:35:58+00:00https://drug.russellpublishing.co.uk/article/31469/the-value-of-automating-assays-in-screening/2020-01-07T16:37:36+00:00https://drug.russellpublishing.co.uk/article/31514/taking-the-brakes-off-the-immune-system/2018-05-02T15:21:42+01:00https://drug.russellpublishing.co.uk/article/31652/antibody-screening-high-throughput/2021-04-30T11:00:41+01:00https://drug.russellpublishing.co.uk/article/31985/could-fingerprints-play-a-role-in-drug-trials-of-the-future-a-forensic-scientists-perspective/2020-01-07T16:43:10+00:00https://drug.russellpublishing.co.uk/article/31997/biomaterials-stem-cell-based/2020-01-14T12:24:17+00:00https://drug.russellpublishing.co.uk/article/32001/regenerative-medicine-cell-bioprocessing/2020-01-14T12:24:25+00:00https://drug.russellpublishing.co.uk/article/32057/drug-target-review-issue-2-2018/2018-09-06T11:47:05+01:00https://drug.russellpublishing.co.uk/article/32066/stem-cells-in-depth-focus-2018/2018-06-29T08:49:18+01:00https://drug.russellpublishing.co.uk/article/32071/imaging-in-depth-focus-2018/2018-06-29T08:47:39+01:00https://drug.russellpublishing.co.uk/article/32077/screening-in-depth-focus-2018/2018-06-29T08:44:16+01:00https://drug.russellpublishing.co.uk/article/32124/using-bioactivity-profiling-to-support-the-progression-of-phenotypic-hits/2021-08-31T10:57:56+01:00https://drug.russellpublishing.co.uk/article/32128/expert-view-discovering-neuronal-cell-types/2018-06-04T12:31:18+01:00https://drug.russellpublishing.co.uk/article/32148/expert-view-improving-rd-productivity-with-novel-screening-approaches/2018-06-04T13:52:33+01:00https://drug.russellpublishing.co.uk/article/32152/expert-view-high-throughput-binding-kinetic-analysis-is-it-the-new-frontier-in-drug-discovery/2018-06-05T13:55:18+01:00https://drug.russellpublishing.co.uk/article/32156/expert-view-preparing-drug-discovery-for-smart-screening-era/2018-09-06T09:00:46+01:00https://drug.russellpublishing.co.uk/article/32165/expert-view-how-high-content-platforms-keep-pace-with-the-changing-face-of-cell-based-drug-screening/2018-06-04T15:22:30+01:00https://drug.russellpublishing.co.uk/article/32170/expert-view-reviewing-the-biggest-innovations-in-antibody-screening/2019-01-17T10:23:21+00:00https://drug.russellpublishing.co.uk/article/32173/expert-view-biological-therapeutics-are-becoming-more-popular-here-are-the-reasons/2018-06-04T15:35:02+01:00https://drug.russellpublishing.co.uk/article/32180/expert-view-overcoming-the-problems-of-working-with-human-primary-hepatocytes/2018-06-11T15:36:03+01:00https://drug.russellpublishing.co.uk/article/32185/automated-assessment-of-liver-and-cardiac-toxicities-in-lead-optimisation/2018-06-04T16:21:51+01:00https://drug.russellpublishing.co.uk/article/32197/expert-view-its-an-exciting-time-for-the-use-of-stem-cells-in-research-and-the-treatment-of-human-disease/2018-09-10T11:46:23+01:00https://drug.russellpublishing.co.uk/article/32204/transforming-translational-research-canscripttm-a-better-predictive-model-for-oncology/2018-06-04T16:48:32+01:00https://drug.russellpublishing.co.uk/article/32220/expert-view-rising-growth-of-the-global-high%e2%80%91content-screening-software-and-services-market/2018-06-04T16:57:40+01:00https://drug.russellpublishing.co.uk/article/32224/streamlining-drug-discovery-assays-for-cancer-and-cardiovascular-disease-2/2018-06-04T17:03:55+01:00https://drug.russellpublishing.co.uk/article/32266/drug-target-review-our-5-steps-to-gdpr-compliance/2018-06-07T09:19:52+01:00https://drug.russellpublishing.co.uk/article/32611/urine-derived-stem-cells/2018-07-20T15:01:19+01:00https://drug.russellpublishing.co.uk/article/32843/how-imaging-biomarkers-are-transforming-drug-development/2019-01-22T12:25:39+00:00https://drug.russellpublishing.co.uk/article/32873/whole-animal-screening-back-to-the-future/2019-01-22T15:24:19+00:00https://drug.russellpublishing.co.uk/article/32891/towards-systems-biomarkers-for-cancer-diagnosis/2019-01-22T15:27:47+00:00https://drug.russellpublishing.co.uk/article/32916/developability-assessment-of-therapeutic-antibodies/2019-01-22T15:26:42+00:00https://drug.russellpublishing.co.uk/article/32940/genomics-in-drug-development-and-safety-testing-from-target-identification-to-genomic-toxicology/2020-01-07T16:57:00+00:00https://drug.russellpublishing.co.uk/article/32952/hts-assays-for-the-identification-of-small-molecule-inhibitors-of-deubiquitinating-enzymes/2019-01-22T15:29:25+00:00https://drug.russellpublishing.co.uk/article/32972/versatile-applications-of-next-generation-sequencing-in-pharmaceutics/2019-01-22T15:30:00+00:00https://drug.russellpublishing.co.uk/article/32986/valid-biomarker-signatures-from-liquid-biopsies-how-to-standardise-ngs/2019-01-22T15:32:56+00:00https://drug.russellpublishing.co.uk/article/32998/practical-application-of-in-vivo-optical-imaging-in-biotherapeutic-biodistribution-analyses/2019-01-22T15:33:24+00:00https://drug.russellpublishing.co.uk/article/33005/a-picture-is-worth-a-thousand-endpoints-high-content-imaging-in-drug-discovery/2019-01-22T15:33:53+00:00https://drug.russellpublishing.co.uk/article/33018/hit-to-lead-in-drug-discovery/2018-07-04T14:28:29+01:00https://drug.russellpublishing.co.uk/article/33026/zebrafish-early-life-stages-as-neurological-screening-and-detection-tools/2018-07-04T14:47:33+01:00https://drug.russellpublishing.co.uk/article/33033/the-next-revolution-in-stratified-medicine-molecular-phenotyping-with-metabolomics/2019-01-23T09:20:41+00:00https://drug.russellpublishing.co.uk/article/33043/pharmacometabolomics-as-the-key-to-personalised-medicine/2019-01-23T09:22:15+00:00https://drug.russellpublishing.co.uk/article/33054/translating-stem-cell-biology-into-drug-discovery/2021-03-11T11:00:29+00:00https://drug.russellpublishing.co.uk/article/33065/mechanism-informed-phenotypic-screening-the-missing-link-for-cancer-drug-discovery/2019-01-23T09:23:45+00:00https://drug.russellpublishing.co.uk/article/33074/analysis-of-human-stem-cell-interactions-at-the-single-cell-resolution/2019-01-23T09:35:45+00:00https://drug.russellpublishing.co.uk/article/33086/antibody-fragment-technology-and-avian-igy-antibodies-a-powerful-combination/2021-08-06T11:45:54+01:00https://drug.russellpublishing.co.uk/article/33099/the-challenges-with-antibody-based-targeting-of-vegf/2018-07-17T15:06:18+01:00https://drug.russellpublishing.co.uk/article/33350/finding-a-cure-for-neglected-tropical-diseases-with-cell-based-assays/2019-01-23T09:34:11+00:00https://drug.russellpublishing.co.uk/article/33367/the-relevance-of-homogeneous-radiometric-assays-in-modern-drug-discovery/2018-07-17T15:07:03+01:00https://drug.russellpublishing.co.uk/article/33380/the-frightening-emergence-of-antibiotic-resistant-bacteria/2018-07-17T15:33:48+01:00https://drug.russellpublishing.co.uk/article/33392/computational-methods-for-drug-repositioning/2018-07-17T16:14:15+01:00https://drug.russellpublishing.co.uk/article/33404/an-overview-of-alzheimers-disease-drug-targets/2018-07-17T16:49:30+01:00https://drug.russellpublishing.co.uk/article/33427/mass-spectrometry-and-systems-biology-approaches-in-drug-target-discovery/2018-07-18T13:56:06+01:00https://drug.russellpublishing.co.uk/article/33435/analysing-recombinant-proteins-by-mass-spectrometry/2018-07-18T14:57:02+01:00https://drug.russellpublishing.co.uk/article/33446/should-lc-ms-ms-proteomics-guide-targeted-drug-selection-for-cancer-patients/2018-07-18T15:27:18+01:00https://drug.russellpublishing.co.uk/article/33455/mass-spectrometry-and-drug-development-how-the-two-come-together/2018-07-18T15:56:57+01:00https://drug.russellpublishing.co.uk/article/33462/trends-in-contemporary-microscopy/2018-07-18T16:29:21+01:00https://drug.russellpublishing.co.uk/article/33476/a-bright-future-for-molecular-probes/2019-01-23T09:42:29+00:00https://drug.russellpublishing.co.uk/article/33509/human-pluripotent-stem-cell-derived-cardiomyocytes-in-drug-discovery-and-development/2018-07-19T11:57:29+01:00https://drug.russellpublishing.co.uk/article/33543/from-fibroblasts-to-medicinal-signalling-cells/2020-01-14T12:24:13+00:00https://drug.russellpublishing.co.uk/article/33568/cancer-drug-screening-the-historical-perspective/2020-01-07T16:59:00+00:00https://drug.russellpublishing.co.uk/article/33586/improving-the-translation-of-disease-biology-though-phenomics/2020-01-07T16:38:50+00:00https://drug.russellpublishing.co.uk/article/33698/applications-of-molecular-imaging-in-drug-development-2/2020-01-07T16:57:46+00:00https://drug.russellpublishing.co.uk/article/33709/exploring-horizons-in-3d-microscopy-what-the-future-holds/2020-01-14T12:24:03+00:00https://drug.russellpublishing.co.uk/article/33721/adapting-drug-discovery-to-artificial-intelligence/2019-04-11T16:33:29+01:00https://drug.russellpublishing.co.uk/article/33740/investigation-of-venom-use-in-stem-cell-differentiation/2018-07-25T12:21:54+01:00https://drug.russellpublishing.co.uk/article/33749/the-importance-of-adequately-triaging-hits-from-hts-campaigns/2019-01-23T09:46:06+00:00https://drug.russellpublishing.co.uk/article/33759/targeting-cancer-metabolism/2019-01-23T09:46:28+00:00https://drug.russellpublishing.co.uk/article/33764/data-automation-in-large-scale-omics-based-biomedical-research/2018-07-25T16:10:53+01:00https://drug.russellpublishing.co.uk/article/33772/lc3-autophagys-achilles-heel/2018-07-25T16:37:30+01:00https://drug.russellpublishing.co.uk/article/33784/immune-checkpoint-inhibitors-targets-on-the-horizon/2018-07-25T16:49:27+01:00https://drug.russellpublishing.co.uk/article/33804/the-therapeutic-potential-of-rna-directed-epigenetic-regulation-of-transcription/2018-07-26T12:09:13+01:00https://drug.russellpublishing.co.uk/article/33893/the-evolving-role-of-three-dimensional-in-vitro-cell-culture-techniques-in-drug-discovery/2020-01-08T16:47:11+00:00https://drug.russellpublishing.co.uk/article/33936/upstream-cell-culture-processes-for-the-production-of-therapeutic-proteins/2020-01-08T16:51:50+00:00https://drug.russellpublishing.co.uk/article/34073/drug-resistance-mechanisms-and-target-selection-in-disease-treatment-strategies/2018-08-07T14:12:54+01:00https://drug.russellpublishing.co.uk/article/34078/targeting-the-ubiquitin-proteasome-system/2018-08-07T14:31:16+01:00https://drug.russellpublishing.co.uk/article/34752/applications-of-high-content-screening-in-autophagy/2020-01-08T16:56:06+00:00https://drug.russellpublishing.co.uk/article/34769/complex-biology-for-the-precision-medicine-era/2020-01-09T16:24:50+00:00https://drug.russellpublishing.co.uk/article/34795/the-changing-face-in-drug-discovery/2020-01-08T17:04:42+00:00https://drug.russellpublishing.co.uk/article/34797/upstream-cell-culture-processes/2020-01-09T16:24:42+00:00https://drug.russellpublishing.co.uk/article/34803/3d-in-vitro-cell-culture-techniques/2020-01-09T16:24:40+00:00https://drug.russellpublishing.co.uk/article/34809/phenotypic-drug-discovery-development/2020-01-09T16:24:31+00:00https://drug.russellpublishing.co.uk/article/34823/monoclonal-antibody-discovery-current-status-and-future-perspectives/2020-01-09T16:24:25+00:00https://drug.russellpublishing.co.uk/article/34825/aggregate-formation-monoclonal-antibodies/2020-01-09T16:24:18+00:00https://drug.russellpublishing.co.uk/article/34829/the-rise-of-high-throughput-flow-cytometry-in-drug-discovery/2020-01-09T16:24:11+00:00https://drug.russellpublishing.co.uk/article/34831/advances-flow-cytometry-drug-discovery/2020-01-09T16:24:08+00:00https://drug.russellpublishing.co.uk/article/34835/ngs-dark-matter-genome-genetic-diseases/2020-01-09T16:23:43+00:00https://drug.russellpublishing.co.uk/article/34838/ngs-single-cell-resolution/2020-01-09T16:24:51+00:00https://drug.russellpublishing.co.uk/article/34979/drug-target-review-issue-3-2018/2018-12-03T12:28:11+00:00https://drug.russellpublishing.co.uk/article/35035/expert-view-new-developments-in-real%e2%80%91time-live%e2%80%91cell-analysis/2018-09-10T11:45:29+01:00https://drug.russellpublishing.co.uk/article/35044/expert-view-managing-the-complexity-of-finding-new-targets-and-drugging-the-undruggable/2018-09-05T12:42:51+01:00https://drug.russellpublishing.co.uk/article/35055/expert-view-assays-to-measure-the-potency-of-therapeutic-antibodies-used-in-combination-with-other-drugs-for-immuno%e2%80%91oncology-treatments/2018-09-05T13:08:45+01:00https://drug.russellpublishing.co.uk/article/35063/expert-view-gmp-proteins-for-therapeutic-manufacturing-combining-consistency-safety-and-supply/2018-09-05T13:32:24+01:00https://drug.russellpublishing.co.uk/article/35068/expert-view-large%e2%80%91scale-stem-cell-expansion-and-differentiation/2018-09-05T14:11:47+01:00https://drug.russellpublishing.co.uk/article/35082/using-bioactivity-profiling-to-support-the-progression-of-phenotypic-hits-2/2021-08-26T10:59:30+01:00https://drug.russellpublishing.co.uk/article/35091/expert-view-multiplexed-screens-in-biologics-discovery/2019-01-17T10:23:55+00:00https://drug.russellpublishing.co.uk/article/35096/expert-view-screen-everything-see-everything/2018-09-05T14:52:22+01:00https://drug.russellpublishing.co.uk/article/35114/expert-view-unravelling-the-complexities-of-gabaa-subunit-selectivity-in-drug-discovery/2018-09-05T15:18:08+01:00https://drug.russellpublishing.co.uk/article/35120/expert-view-tools-for-compliance-with-21-cfr-part-11/2018-09-05T15:27:25+01:00https://drug.russellpublishing.co.uk/article/35126/expert-view-generate-high%e2%80%91content-information-using-flow-cytometry/2018-09-05T15:37:25+01:00https://drug.russellpublishing.co.uk/article/35131/expert-view-challenges-in-flow-cytometry/2019-01-17T10:25:42+00:00https://drug.russellpublishing.co.uk/article/35135/cell-based-and-biochemical-high-throughput-screening-in-1536-well-plates/2018-09-05T15:58:36+01:00https://drug.russellpublishing.co.uk/article/35141/improved-screening-of-therapeutic-candidates-using-integrated-fragment-based-approaches/2018-09-05T16:07:23+01:00https://drug.russellpublishing.co.uk/article/35147/expert-view-the-development-of-single%e2%80%91cell-genomics-with-smart%e2%80%91seq/2018-09-05T16:20:25+01:00https://drug.russellpublishing.co.uk/article/35169/antibodies-in-depth-focus-2018/2018-10-02T11:12:53+01:00https://drug.russellpublishing.co.uk/article/35178/assays-in-depth-focus-2018-2/2018-11-28T13:37:49+00:00https://drug.russellpublishing.co.uk/article/35185/next-generation-sequencing-in-depth-focus-2018/2018-09-10T14:00:58+01:00https://drug.russellpublishing.co.uk/article/35201/flow-cytometry-in-depth-focus-2018/2018-09-10T14:00:17+01:00https://drug.russellpublishing.co.uk/article/35250/upstream-bioprocessing-in-depth-focus-2018/2018-09-10T13:59:18+01:00https://drug.russellpublishing.co.uk/article/35419/synthetic-biology-in-drug-discovery/2020-01-08T17:13:06+00:00https://drug.russellpublishing.co.uk/article/35448/pharmacological-targeting-of-mitochondrial-dysfunction-in-parkinsons-disease/2020-01-09T16:24:49+00:00https://drug.russellpublishing.co.uk/article/35746/metabolomics-drug-biomarker-discovery/2020-01-08T17:16:37+00:00https://drug.russellpublishing.co.uk/article/35772/expert-view-creating-metabolic-liabilities-to-target-cancer/2018-09-25T16:59:04+01:00https://drug.russellpublishing.co.uk/article/35979/exploring-quality-of-life-for-stoma-patients/2020-01-08T17:28:16+00:00https://drug.russellpublishing.co.uk/article/36595/high-throughput-screening-platforms-incorporating-physiologically-relevant-3-d-models/2019-01-22T12:14:12+00:00https://drug.russellpublishing.co.uk/article/36916/high-throughput-intracellular-atp-levels/2020-01-10T12:13:48+00:00https://drug.russellpublishing.co.uk/article/37067/drug-transporters-phenotypic-screening/2020-01-10T12:13:49+00:00https://drug.russellpublishing.co.uk/article/37163/hts-collaborative-drug-discovery/2020-01-10T12:13:38+00:00https://drug.russellpublishing.co.uk/article/37410/targeting-innate-immunity/2020-01-09T12:25:50+00:00https://drug.russellpublishing.co.uk/article/37441/drug-target-review-issue-4-2018/2019-03-14T14:57:58+00:00https://drug.russellpublishing.co.uk/article/37453/targets-in-depth-focus-2018/2019-02-27T09:41:22+00:00https://drug.russellpublishing.co.uk/article/37462/screening-in-depth-focus-2018-2/2019-02-28T15:52:44+00:00https://drug.russellpublishing.co.uk/article/37463/pains-management-an-open-source-model-to-eliminate-nuisance-compounds/2020-01-10T12:13:21+00:00https://drug.russellpublishing.co.uk/article/37468/hit-to-lead-in-depth-focus-2018/2019-02-28T15:54:57+00:00https://drug.russellpublishing.co.uk/article/37532/under-the-microscope-cros-and-microplate-reader-requirements/2018-12-04T11:34:51+00:00https://drug.russellpublishing.co.uk/article/37541/expert-view-tackling-drug-discovery-inefficiencies-requires-diverse-libraries-technologies-with-broader-applicability-and-actionable-insights/2018-12-19T08:44:11+00:00https://drug.russellpublishing.co.uk/article/37547/expert-view-high-throughput-screening-make-an-impact-by-removing-barriers/2018-12-04T12:13:30+00:00https://drug.russellpublishing.co.uk/article/37548/self-delivering-rnai-immunotherapies/2020-01-10T12:13:23+00:00https://drug.russellpublishing.co.uk/article/37552/webinar-highlights-cell-based-and-biochemical-high-throughput-screening-in-1536-well-plates/2018-12-04T14:15:51+00:00https://drug.russellpublishing.co.uk/article/37558/expert-view-three-dimensional-cell-cultures-as-predictive-tools-in-early-drug-discovery/2018-12-04T14:13:32+00:00https://drug.russellpublishing.co.uk/article/37577/application-notes-supplement-2018/2019-03-01T09:59:21+00:00https://drug.russellpublishing.co.uk/article/37592/expert-view-challenges-in-drug-discovery-screening/2018-12-04T14:25:27+00:00https://drug.russellpublishing.co.uk/article/37596/expert-view-recent-advances-in-diagnostics-and-treatments-from-small-molecules-to-cellular-therapies/2018-12-07T10:33:09+00:00https://drug.russellpublishing.co.uk/article/37604/webinar-highlights-integrated-fragment-based-approach-reveals-enzymatic-inhibitors-with-potential-therapeutic-application/2018-12-04T15:05:40+00:00https://drug.russellpublishing.co.uk/article/37613/webinar-highlights-harmonising-drug-target-binding-data-analytics-on-a-single-platform/2018-12-07T10:28:16+00:00https://drug.russellpublishing.co.uk/article/37618/webinar-preview-compliance-with-data-integrity-and-computerised-system-validations/2018-12-04T15:26:16+00:00https://drug.russellpublishing.co.uk/article/37871/omics-informed-drug-target-discovery/2020-01-09T12:27:08+00:00https://drug.russellpublishing.co.uk/article/37951/proteomics-molecular-mystery/2020-01-10T12:13:11+00:00https://drug.russellpublishing.co.uk/article/37998/g-protein-coupled-receptor-drug-discovery/2021-03-11T15:27:33+00:00https://drug.russellpublishing.co.uk/article/38041/high-content-assays-for-drug-discovery/2020-01-09T12:16:54+00:00https://drug.russellpublishing.co.uk/article/38806/small-molecules-cancers/2019-03-26T09:08:38+00:00https://drug.russellpublishing.co.uk/article/39292/how-next-generation-sequencing-came-to-be-a-brief-history/2019-01-31T13:36:10+00:00https://drug.russellpublishing.co.uk/article/39659/heat-shock-proteins-a-high-content-assay-opportunity-to-measure-cellular-stress-response/2019-01-31T15:07:32+00:00https://drug.russellpublishing.co.uk/article/39904/hit-to-lead-discovery-at-a-nonprofit-research-institute/2019-04-02T16:27:03+01:00https://drug.russellpublishing.co.uk/article/41057/drug-target-review-issue-1-2019/2019-08-09T16:00:34+01:00https://drug.russellpublishing.co.uk/article/41078/assays-in-depth-focus-2019/2020-06-09T08:34:12+01:00https://drug.russellpublishing.co.uk/article/41102/lab-automation-in-depth-focus-2019/2020-06-09T08:33:45+01:00https://drug.russellpublishing.co.uk/article/41111/informatics-in-depth-focus-2019/2020-06-09T08:33:56+01:00https://drug.russellpublishing.co.uk/article/41203/cell-line-development-global-market-drivers-trends-and-its-impact-on-improving-biologics-development-from-early-phase-to-ind-during-the-drug-discovery-process/2020-01-09T12:29:30+00:00https://drug.russellpublishing.co.uk/article/41220/drug-discovery-from-the-age-of-information-to-the-age-of-intelligence/2020-01-09T12:28:13+00:00https://drug.russellpublishing.co.uk/article/41232/adme-toxicity-assays/2020-01-09T12:33:53+00:00https://drug.russellpublishing.co.uk/article/41841/kick-starting-the-immune-response-the-shifting-landscape-of-immuno-oncology/2019-04-02T14:38:27+01:00https://drug.russellpublishing.co.uk/article/42538/realising-the-promise-of-laboratory-automation-in-biomedical-research/2020-01-10T11:55:46+00:00https://drug.russellpublishing.co.uk/article/42552/transforming-drug-discovery-development-and-delivery-with-flow-chemistry/2020-01-10T11:55:49+00:00https://drug.russellpublishing.co.uk/article/43058/squaring-the-circle-cancer-vaccines/2020-01-10T11:54:58+00:00https://drug.russellpublishing.co.uk/article/43067/farther-than-fat-how-lipidomics-change-research/2021-03-11T11:12:22+00:00https://drug.russellpublishing.co.uk/article/43552/network-driven-drug-discovery/2020-01-09T12:32:03+00:00https://drug.russellpublishing.co.uk/article/43795/ai-driven-automated-chemistry-as-a-tool-to-accelerate-drug-discovery/2021-03-10T15:06:07+00:00https://drug.russellpublishing.co.uk/article/44295/drug-target-review-issue-2-2019/2019-12-10T09:07:27+00:00https://drug.russellpublishing.co.uk/article/44304/stem-cell-in-depth-focus-2019/2019-08-12T16:07:44+01:00https://drug.russellpublishing.co.uk/article/44387/imaging-in-depth-focus-2019/2019-08-12T16:08:08+01:00https://drug.russellpublishing.co.uk/article/44412/why-do-we-have-no-effective-treatments-for-osteoarthritis/2020-01-10T11:55:38+00:00https://drug.russellpublishing.co.uk/article/44422/phenotypic-profiling-in-drug-discovery/2020-01-13T14:34:25+00:00https://drug.russellpublishing.co.uk/article/44536/screening-in-depth-focus-2019/2019-08-12T16:08:56+01:00https://drug.russellpublishing.co.uk/article/44560/expert-view-high-content-screening-complex-physiologically-relevant-cell-models/2019-06-10T09:20:51+01:00https://drug.russellpublishing.co.uk/article/44674/crispr-cas9-engineered-cancer-models/2020-01-13T14:34:20+00:00https://drug.russellpublishing.co.uk/article/44716/radiochemistry-and-drug-synthesis-in-a-flash/2020-05-22T12:09:00+01:00https://drug.russellpublishing.co.uk/article/44772/bringing-native-analysis-into-the-fast-moving-world-of-biologics/2020-01-13T14:33:48+00:00https://drug.russellpublishing.co.uk/article/45000/compound-and-fragment-screening-by-native-mass-spectrometry/2020-01-13T14:33:09+00:00https://drug.russellpublishing.co.uk/article/45002/screening-beyond-in-drug-discovery/2020-01-13T14:33:25+00:00https://drug.russellpublishing.co.uk/article/45122/high-content-imaging-challenges-of-3d-world/2020-01-13T14:32:36+00:00https://drug.russellpublishing.co.uk/article/45144/image-based-characterisation-of-cancer-biotherapeutics/2020-01-13T14:33:06+00:00https://drug.russellpublishing.co.uk/article/45241/stem-cell-technologies-in-immunotherapy/2020-01-13T14:32:42+00:00https://drug.russellpublishing.co.uk/article/45249/stem-cells-effects-cannabis-neuronal-development/2020-01-13T14:32:58+00:00https://drug.russellpublishing.co.uk/article/45973/artificial-intelligence-in-the-world-of-drug-discovery/2019-07-03T15:34:03+01:00https://drug.russellpublishing.co.uk/article/46074/discovering-new-routes-to-cancer-drug-discovery-with-neutrons/2019-07-09T15:23:47+01:00https://drug.russellpublishing.co.uk/article/46301/five-latest-developments-for-models/2019-07-11T16:08:59+01:00https://drug.russellpublishing.co.uk/article/47078/encouraging-drug-discovery-and-therapeutic-targets-for-dementia/2019-07-26T15:07:25+01:00https://drug.russellpublishing.co.uk/article/47556/five-newest-developments-for-imaging-in-drug-research/2019-08-12T08:22:03+01:00https://drug.russellpublishing.co.uk/article/47713/applying-ai-language-translation-to-the-creation-of-new-pharmaceuticals/2019-09-05T08:37:57+01:00https://drug.russellpublishing.co.uk/article/47784/beyond-the-phenotype-using-ai-to-better-understand-disease/2019-08-16T14:40:04+01:00https://drug.russellpublishing.co.uk/article/47942/uniting-humans-and-data-the-role-of-ai-in-genomics/2019-08-27T13:49:59+01:00https://drug.russellpublishing.co.uk/article/48244/what-are-the-pros-and-cons-of-using-organoids/2019-08-27T16:50:23+01:00https://drug.russellpublishing.co.uk/article/48493/the-promise-and-pitfalls-of-serial-femtosecond-x-ray-crystallography/2019-09-04T15:35:41+01:00https://drug.russellpublishing.co.uk/article/48637/five-recent-parkinsons-disease-drug-target-discoveries/2019-09-10T09:57:41+01:00https://drug.russellpublishing.co.uk/article/48641/drug-target-review-issue-3-2019/2019-12-10T09:05:44+00:00https://drug.russellpublishing.co.uk/article/48669/designing-proteins-from-scratch-computer-science/2020-12-17T16:42:27+00:00https://drug.russellpublishing.co.uk/article/48718/integrating-drug-discovery-rd/2019-09-17T12:50:59+01:00https://drug.russellpublishing.co.uk/article/48728/antibodies-in-depth-focus-2019/2019-12-10T09:20:01+00:00https://drug.russellpublishing.co.uk/article/48731/slowing-progression-in-parkinsons/2019-09-18T21:10:05+01:00https://drug.russellpublishing.co.uk/article/48737/genomics-in-depth-focus-2019/2019-12-10T09:14:57+00:00https://drug.russellpublishing.co.uk/article/48744/upstream-bioprocessing-in-depth-focus-2019/2019-12-10T09:16:15+00:00https://drug.russellpublishing.co.uk/article/48750/evaluation-of-therapeutic-antibody-discovery-technologies/2021-04-30T10:51:38+01:00https://drug.russellpublishing.co.uk/article/48786/hitting-the-target-utilising-recombinant-antibodies-for-viral-research/2020-12-17T16:46:44+00:00https://drug.russellpublishing.co.uk/article/48814/spotlighting-data-upstream-bioprocesses-successful-cell-lines/2020-12-17T16:42:13+00:00https://drug.russellpublishing.co.uk/article/48868/expert-view-clarification-of-cell-cultures-without-centrifugation/2019-09-25T15:21:49+01:00https://drug.russellpublishing.co.uk/article/48918/genomic-medicine-cracking-genomes-to-cure-incurable-diseases/2020-12-17T16:43:52+00:00https://drug.russellpublishing.co.uk/article/48933/the-elegant-parallel-of-using-crispr-to-understand-disease-mechanisms/2020-12-17T16:42:34+00:00https://drug.russellpublishing.co.uk/article/48962/training-and-development-in-flow-cytometry-and-other-core-technologies/2020-12-17T16:46:53+00:00https://drug.russellpublishing.co.uk/article/48999/recent-trends-upstream-bioprocessing-challenge-process-development/2020-12-17T16:00:21+00:00https://drug.russellpublishing.co.uk/article/49000/next-generation-sequencing-for-cancer-precision-medicine/2019-09-18T20:29:41+01:00https://drug.russellpublishing.co.uk/article/49085/expert-view-call-to-action-establishing-the-protein-binding-properties-of-oligonucleotides/2019-09-25T15:23:39+01:00https://drug.russellpublishing.co.uk/article/49128/expert-view-engineered-antibodies-semi-rational-design-approach-for-faster-optimisation/2019-09-25T15:24:00+01:00https://drug.russellpublishing.co.uk/article/49157/expert-view-advancing-antibody-discovery-with-picodroplet-technology/2019-10-10T14:02:08+01:00https://drug.russellpublishing.co.uk/article/49179/getting-connected-the-key-to-solving-the-reproducibility-problem/2020-12-17T16:46:19+00:00https://drug.russellpublishing.co.uk/article/49208/expert-view-the-importance-of-accurate-synthetic-dna-fragments/2019-09-23T13:36:23+01:00https://drug.russellpublishing.co.uk/article/49332/expert-view-opportunities-in-flow-cytometry/2019-09-18T10:00:56+01:00https://drug.russellpublishing.co.uk/article/49385/expert-view-bio-rads-comprehensive-genomics-portfolio-provides-answers-for-every-problem/2019-09-17T12:40:35+01:00https://drug.russellpublishing.co.uk/article/49416/expert-view-what-role-do-connected-pipettes-play-in-the-lab-of-the-future/2019-10-11T15:23:34+01:00https://drug.russellpublishing.co.uk/article/49466/under-the-microscope-collaborating-in-target-discovery/2019-10-28T14:15:24+00:00https://drug.russellpublishing.co.uk/article/49468/therapeutic-antibodies-in-cancer-therapy/2020-12-17T16:00:09+00:00https://drug.russellpublishing.co.uk/article/49476/under-the-microscope-improving-hit-discovery-efficiency-at-europes-leading-screening-centre/2019-09-17T15:22:34+01:00https://drug.russellpublishing.co.uk/article/50080/a-biosynthetic-pathway-to-identify-new-drug-candidates/2019-10-28T14:14:57+00:00https://drug.russellpublishing.co.uk/article/50524/the-challenges-of-hit-to-lead-in-drug-discovery/2019-10-28T14:14:15+00:00https://drug.russellpublishing.co.uk/article/51431/sel120-a-promising-cdk8-kinase-inhibitor/2019-10-28T15:20:50+00:00https://drug.russellpublishing.co.uk/article/52335/a-novel-target-revealed-for-myelodysplastic-syndrome/2019-11-21T14:57:19+00:00https://drug.russellpublishing.co.uk/article/52485/how-will-crispr-evolve-in-the-future/2019-11-26T08:23:00+00:00https://drug.russellpublishing.co.uk/article/52849/progression-trends-and-industry-leaders-in-hiv-and-aids-research/2019-12-06T10:49:42+00:00https://drug.russellpublishing.co.uk/article/52870/drug-target-review-issue-4-2019/2020-03-23T12:19:10+00:00https://drug.russellpublishing.co.uk/article/52908/screening-in-depth-focus-2019-2/2020-03-23T13:56:21+00:00https://drug.russellpublishing.co.uk/article/52912/targets-in-depth-focus-2019/2020-03-23T13:58:15+00:00https://drug.russellpublishing.co.uk/article/52957/five-recent-drug-target-discoveries-for-pancreatic-cancer/2020-01-15T12:13:22+00:00https://drug.russellpublishing.co.uk/article/52970/hit-to-lead-in-depth-focus-2019/2020-03-23T13:58:36+00:00https://drug.russellpublishing.co.uk/article/53070/championing-genomics-in-the-uk/2019-12-12T15:39:10+00:00https://drug.russellpublishing.co.uk/article/53073/the-implication-of-a-dysfunctional-proteasome-regulator-in-neurodegenerative-disease/2019-12-13T11:20:52+00:00https://drug.russellpublishing.co.uk/article/53080/using-droplet-digital-pcr-to-monitor-the-safety-of-car-t-cells/2020-12-17T16:30:12+00:00https://drug.russellpublishing.co.uk/article/53093/open-innovation-a-collaboration-between-academia-and-the-pharmaceutical-industry-to-further-leverage-drug-discovery-expertise-and-assets/2020-12-17T16:01:00+00:00https://drug.russellpublishing.co.uk/article/53152/crispr-kick-starting-the-revolution-in-drug-discovery/2020-12-17T16:00:44+00:00https://drug.russellpublishing.co.uk/article/53185/antibody-characterisation-an-essential-researchers-resource/2020-12-17T15:58:42+00:00https://drug.russellpublishing.co.uk/article/53204/a-novel-approach-to-unravelling-the-mysteries-of-alzheimers/2020-12-17T15:57:50+00:00https://drug.russellpublishing.co.uk/article/53214/advances-in-mass-spectrometry-unlocking-the-potential-of-chemical-crosslinking-as-a-structural-biology-tool/2020-12-17T15:56:54+00:00https://drug.russellpublishing.co.uk/article/53288/expert-view-following-mitchondrial-substrate-oxidation-pathways-to-expose-novel-drug-targets/2019-12-12T14:35:32+00:00https://drug.russellpublishing.co.uk/article/53310/expert-view-promising-methods-in-kinase-screening/2019-12-12T13:52:52+00:00https://drug.russellpublishing.co.uk/article/53327/expert-view-understanding-the-fast-evolving-immune-oncology-landscape/2019-12-12T14:32:52+00:00https://drug.russellpublishing.co.uk/article/53339/getting-precise-how-humanised-models-aid-in-biologics-drug-discovery/2019-12-17T10:42:22+00:00https://drug.russellpublishing.co.uk/article/53340/expert-view-the-octet-htx-system-enabling-multi-purpose-screening-of-therapeutic-biologics-during-development/2019-12-12T14:59:16+00:00https://drug.russellpublishing.co.uk/article/53363/hit-to-lead-in-neglected-diseases-its-a-numbers-game/2019-12-16T14:55:01+00:00https://drug.russellpublishing.co.uk/article/53367/expert-view-the-future-of-cell-expansion-for-monoclonal-antibody-production/2019-12-12T15:35:34+00:00https://drug.russellpublishing.co.uk/article/53386/transitioning-novel-peptide-hits-into-lead-compounds/2019-12-16T11:47:22+00:00https://drug.russellpublishing.co.uk/article/53419/exploring-chemical-space-for-epigenetic-drug-discovery-using-ai/2019-12-17T11:00:15+00:00https://drug.russellpublishing.co.uk/article/53549/is-a-universal-vaccine-against-cancer-possible/2019-12-13T14:44:34+00:00https://drug.russellpublishing.co.uk/article/53909/dtrs-news-round-up-2019-the-stories-that-defined-the-year/2019-12-18T14:06:31+00:00https://drug.russellpublishing.co.uk/article/54235/rna-and-machine-learning-rational-design-for-multidimensional-biomarkers/2020-01-09T08:21:16+00:00https://drug.russellpublishing.co.uk/article/54853/five-of-the-latest-cancer-stem-cell-discoveries/2020-01-15T13:35:03+00:00https://drug.russellpublishing.co.uk/article/54897/novel-sex-linked-targets-provide-autoimmune-disease-therapies/2020-01-17T11:52:11+00:00https://drug.russellpublishing.co.uk/article/55276/developing-an-algorithm-to-predict-drug-induced-liver-injury/2020-01-23T12:17:07+00:00https://drug.russellpublishing.co.uk/article/55362/the-growing-possibilities-for-stem-cells-in-pharma/2020-01-30T09:22:39+00:00https://drug.russellpublishing.co.uk/article/55550/body-on-chip-technology-resolving-current-limitations-in-drug-discovery/2020-01-30T16:04:57+00:00https://drug.russellpublishing.co.uk/article/55786/could-the-gut-microbiome-be-the-key-to-new-antidepressant-therapies/2020-02-12T10:02:39+00:00https://drug.russellpublishing.co.uk/article/55999/elrig-and-the-british-pharmacological-society-why-form-a-strategic-alliance/2020-02-13T14:04:45+00:00https://drug.russellpublishing.co.uk/article/56159/discovering-how-drugs-combat-hiv-and-why-resistance-can-occur/2020-02-17T12:11:24+00:00https://drug.russellpublishing.co.uk/article/56305/novel-molecules-to-adjust-the-circadian-rhythm/2020-02-19T15:51:46+00:00https://drug.russellpublishing.co.uk/article/56366/discovering-and-designing-drugs-with-artificial-intelligence/2020-02-20T17:00:02+00:00https://drug.russellpublishing.co.uk/article/56467/could-dolphins-be-viable-models-for-human-brain-disorders/2020-02-24T12:18:59+00:00https://drug.russellpublishing.co.uk/article/56488/why-invest-in-creating-a-modifiable-drug-framework/2020-03-02T14:48:10+00:00https://drug.russellpublishing.co.uk/article/56668/developing-an-automatic-microfluidic-platform-using-ferrobots/2020-03-10T11:57:27+00:00https://drug.russellpublishing.co.uk/article/56773/rebalancing-the-immune-system-to-treat-autoimmune-disease/2020-03-02T16:06:55+00:00https://drug.russellpublishing.co.uk/article/57052/using-virtual-screening-to-identify-coronavirus-treatments/2020-03-13T15:45:57+00:00https://drug.russellpublishing.co.uk/article/57150/exploring-future-spinal-cord-injury-therapies/2020-03-11T16:17:47+00:00https://drug.russellpublishing.co.uk/article/57265/safer-and-more-affordable-medicine-for-all-how-pharmacogenomics-may-level-the-playing-field/2020-03-16T11:10:32+00:00https://drug.russellpublishing.co.uk/article/57485/inhibiting-the-epichaperome-to-combat-alzheimers-disease/2021-02-04T10:09:21+00:00https://drug.russellpublishing.co.uk/article/57497/targeted-protein-degradation-the-next-wave-of-therapeutics/2020-03-17T13:37:11+00:00https://drug.russellpublishing.co.uk/article/57610/where-could-bioengineering-and-technological-advances-take-drug-discovery/2020-03-19T12:26:41+00:00https://drug.russellpublishing.co.uk/article/57777/drug-target-review-issue-1-2020/2020-05-29T14:22:48+01:00https://drug.russellpublishing.co.uk/article/57780/pooling-research-and-development-resources-to-tackle-emerging-threats/2020-03-25T14:51:38+00:00https://drug.russellpublishing.co.uk/article/57784/cell-line-development-for-therapeutic-proteins-current-perspectives-and-future-opportunities/2020-12-17T15:48:15+00:00https://drug.russellpublishing.co.uk/article/57811/assays-in-depth-focus-2020/2020-06-10T08:37:44+01:00https://drug.russellpublishing.co.uk/article/57815/lab-automation-in-depth-focus-2020/2020-06-10T08:32:09+01:00https://drug.russellpublishing.co.uk/article/57822/antibodies-in-depth-focus-2020/2020-06-08T15:29:38+01:00https://drug.russellpublishing.co.uk/article/57824/informatics-in-depth-focus-2020/2020-06-10T08:51:54+01:00https://drug.russellpublishing.co.uk/article/57898/in-vitro-platforms-for-de-risking-nephrotoxicity-during-drug-development/2020-12-17T15:51:25+00:00https://drug.russellpublishing.co.uk/article/57933/genomic-assays-on-the-brink-of-revolutionising-human-healthcare/2020-12-17T15:48:27+00:00https://drug.russellpublishing.co.uk/article/57987/tcr-therapy-an-attractive-alternative-to-car-t/2020-03-26T10:00:09+00:00https://drug.russellpublishing.co.uk/article/58040/scientific-data-management-the-core-of-quality/2020-12-17T15:46:47+00:00https://drug.russellpublishing.co.uk/article/58060/laboratory-automation-in-early-drug-discovery/2021-03-11T15:12:08+00:00https://drug.russellpublishing.co.uk/article/58121/the-race-to-find-a-coronavirus-treatment-are-antibodies-the-answer/2020-12-17T15:38:18+00:00https://drug.russellpublishing.co.uk/article/58123/expert-view-the-path-to-the-high-hanging-fruit-access-to-greater-diversity-and-rapid-down-selection/2020-04-07T11:09:36+01:00https://drug.russellpublishing.co.uk/article/58135/not-everyone-loves-surprises-know-your-adcs-critical-quality-attributes/2020-12-17T15:39:38+00:00https://drug.russellpublishing.co.uk/article/58149/expert-view-targeting-the-cgas-sting-pathway-with-a-new-transcreener-hts-assay/2020-03-24T17:30:59+00:00https://drug.russellpublishing.co.uk/article/58168/expert-view-are-you-ready-for-next-generatoin-therapeutic-antibodies/2020-03-24T18:35:24+00:00https://drug.russellpublishing.co.uk/article/58219/antibodies-allow-for-a-targeted-approach-to-cancer-therapy/2020-12-17T15:37:14+00:00https://drug.russellpublishing.co.uk/article/58234/petabytes-of-data-how-informatics-is-transforming-precision-medicine/2020-12-17T15:41:40+00:00https://drug.russellpublishing.co.uk/article/58250/how-labs-become-ai-ready-with-advanced-informatics-infrastructures/2020-12-17T15:36:25+00:00https://drug.russellpublishing.co.uk/article/58291/expert-view-how-automation-can-improve-cell-stability-and-productivity-in-cell-line-development/2020-03-31T16:58:14+01:00https://drug.russellpublishing.co.uk/article/58301/expert-view-early-product-characterisation-mitigates-risks-in-biologics-development/2021-03-10T15:33:01+00:00https://drug.russellpublishing.co.uk/article/58462/the-latest-developments-in-diabetes-drug-discovery/2021-03-10T15:16:54+00:00https://drug.russellpublishing.co.uk/article/58628/host-pathways-in-coronavirus-replication-and-covid-19-pre-clinical-drug-target-identification-using-proteomic-and-chemoinformatic-analysis/2020-03-30T10:07:56+01:00https://drug.russellpublishing.co.uk/article/59097/how-are-seasonal-influenza-vaccines-developing/2020-04-01T16:41:20+01:00https://drug.russellpublishing.co.uk/article/59467/predicting-which-diabetes-treatments-will-reach-clinical-trials/2020-04-06T15:43:28+01:00https://drug.russellpublishing.co.uk/article/59754/covid-19-and-big-pharma-what-are-15-leading-companies-doing-to-develop-a-coronavirus-vaccine/2020-04-09T09:38:53+01:00https://drug.russellpublishing.co.uk/article/59784/refreshing-how-we-approach-neuroscience-with-a-novel-screening-technology/2020-04-09T14:52:23+01:00https://drug.russellpublishing.co.uk/article/59804/gender-specific-coronavirus-infections-in-the-light-of-evolution/2020-04-29T14:20:17+01:00https://drug.russellpublishing.co.uk/article/59819/the-coronavirus-as-a-personalised-enemy-of-mankind/2020-04-29T14:20:55+01:00https://drug.russellpublishing.co.uk/article/59826/mesenchymal-stem-cells-secretome-as-a-prospective-therapeutic-option-for-covid-19-patients/2020-04-09T16:53:32+01:00https://drug.russellpublishing.co.uk/article/60234/high-throughput-screening-for-antibody-based-drugs/2020-04-16T15:10:55+01:00https://drug.russellpublishing.co.uk/article/60516/developing-immunotherapies-for-hard-to-treat-cancers/2020-04-23T09:39:38+01:00https://drug.russellpublishing.co.uk/article/60593/histone-deacetylase-2-hdac2-regulates-pathological-response-of-inflammatory-monocytes-a-potential-target-of-adjuvant-therapies-for-covid-19-infection/2020-04-23T17:04:23+01:00https://drug.russellpublishing.co.uk/article/60660/natural-peptides-versus-covid-19/2020-04-24T12:22:58+01:00https://drug.russellpublishing.co.uk/article/60832/cytokine-storms-a-major-killer-in-patients-with-severe-covid-19-infection/2020-04-27T16:54:21+01:00https://drug.russellpublishing.co.uk/article/60896/developing-respiratory-therapeutics-for-prophylaxis-and-treatment/2020-04-28T12:10:55+01:00https://drug.russellpublishing.co.uk/article/60902/intravenous-immunoglobulins-hyperimmunes-and-pandemic-viruses/2020-04-28T12:12:57+01:00https://drug.russellpublishing.co.uk/article/61280/begin-with-the-end-in-mind-designing-synthetic-antibiotics-with-a-universal-mechanism-of-action/2020-05-06T13:55:00+01:00https://drug.russellpublishing.co.uk/article/61474/utilising-an-interleukin-12-plasmid-a-novel-covid-19-vaccine/2020-05-13T14:03:02+01:00https://drug.russellpublishing.co.uk/article/61481/empty-phage-viruses-as-a-method-to-combat-influenza/2021-02-10T11:43:05+00:00https://drug.russellpublishing.co.uk/article/61541/using-scientific-literature-to-aid-the-development-of-a-safe-and-effective-covid-19-vaccine/2020-09-30T20:57:28+01:00https://drug.russellpublishing.co.uk/article/61581/can-a-computer-help-us-find-a-treatment-for-covid-19/2020-05-18T12:06:32+01:00https://drug.russellpublishing.co.uk/article/61649/chemical-formulas-relevant-to-covid-19-drug-targets/2020-05-19T15:36:04+01:00https://drug.russellpublishing.co.uk/article/61652/using-pharmacologically-established-medicines-to-treat-covid-19/2020-05-19T15:37:37+01:00https://drug.russellpublishing.co.uk/article/61657/tmprss2-inhibitors-bromhexine-aprotinin-camostat-and-nafamostat-as-potential-treatments-for-covid-19/2020-05-19T15:44:38+01:00https://drug.russellpublishing.co.uk/article/61734/drug-target-review-issue-2-2020/2020-09-08T11:49:55+01:00https://drug.russellpublishing.co.uk/article/61738/screening-in-depth-focus-2020/2020-09-08T11:53:33+01:00https://drug.russellpublishing.co.uk/article/61740/immuno-oncology-in-depth-focus-2020/2020-09-08T11:53:21+01:00https://drug.russellpublishing.co.uk/article/61746/imaging-in-depth-focus-2020/2020-09-08T11:52:04+01:00https://drug.russellpublishing.co.uk/article/61757/stem-cells-in-deth-focus-2020/2020-09-08T11:52:08+01:00https://drug.russellpublishing.co.uk/article/61880/the-crick-hts-facility-facilitating-research-through-large-scale-screening/2020-12-17T15:48:03+00:00https://drug.russellpublishing.co.uk/article/61883/high-throughput-screening-as-a-method-for-discovering-new-drugs/2020-12-17T15:47:33+00:00https://drug.russellpublishing.co.uk/article/61887/if-columbus-had-a-map-guiding-the-discovery-of-new-drugs/2020-12-17T15:55:35+00:00https://drug.russellpublishing.co.uk/article/61926/current-state-of-nafld-treatments-and-the-promise-of-in-vitro-platforms-towards-better-screening-of-drug-candidates/2020-12-17T15:53:56+00:00https://drug.russellpublishing.co.uk/article/61970/triplet-immuno-oncology-drug-combinations/2020-12-17T15:53:46+00:00https://drug.russellpublishing.co.uk/article/62037/neoantigens-presenting-new-vaccine-opportunities-in-immuno-oncology/2020-12-17T15:53:32+00:00https://drug.russellpublishing.co.uk/article/62057/data-data-and-still-more-data-the-challenges-of-imaging-and-analysing-3d-cell-models/2020-12-17T15:44:39+00:00https://drug.russellpublishing.co.uk/article/62063/expert-view-critical-consumables-meeting-the-need-for-a-steady-supply-of-microplates/2020-05-28T18:32:17+01:00https://drug.russellpublishing.co.uk/article/62114/genetics-drug-targets-fibrotic-lung-diseases/2020-12-17T15:45:13+00:00https://drug.russellpublishing.co.uk/article/62186/seeing-the-light-visualising-protein-translation-in-real-time/2020-12-17T15:44:57+00:00https://drug.russellpublishing.co.uk/article/62204/expert-view-finding-a-translatable-disease-model-suitable-for-drug-discovery-screening/2020-05-28T18:32:38+01:00https://drug.russellpublishing.co.uk/article/62212/expert-view-crispr-screening-a-powerful-approach-to-drug-discovery-and-development/2020-05-28T18:30:42+01:00https://drug.russellpublishing.co.uk/article/62300/using-big-data-approaches-to-develop-cell-therapies/2020-12-17T15:45:26+00:00https://drug.russellpublishing.co.uk/article/62314/application-of-organoid-technology-for-retinal-disease-modelling-and-drug-discovery/2020-12-16T14:38:57+00:00https://drug.russellpublishing.co.uk/article/62370/antibodies-against-viral-disease-highlighting-technologies-behind-covid-19-antibody-therapy/2020-12-17T15:48:27+00:00https://drug.russellpublishing.co.uk/article/62375/delivering-a-therapy-to-kerb-covid-19/2020-12-17T15:48:16+00:00https://drug.russellpublishing.co.uk/article/62381/expert-view-high-throughput-analytics-for-smarter-cell-line-development/2020-06-01T16:28:23+01:00https://drug.russellpublishing.co.uk/article/62389/expert-view-from-3d-high-throughput-to-simple-automated-imaging-cellular-imaging-within-reach-of-every-laboratory/2020-06-04T14:46:02+01:00https://drug.russellpublishing.co.uk/article/62400/expert-view-delivering-better-therapeutics-fully-characterising-and-recovering-t-cells/2020-06-01T17:10:08+01:00https://drug.russellpublishing.co.uk/article/62409/expert-view-genscripts-unique-four-tier-platform-for-successful-synthesis-of-challenging-neoantigen-peptides-for-precision-medicine/2020-06-01T17:38:21+01:00https://drug.russellpublishing.co.uk/article/62522/the-effect-of-temperature-and-humidity-on-the-number-of-cases-and-deaths-of-covid-19-all-over-the-world/2020-06-13T12:51:48+01:00https://drug.russellpublishing.co.uk/article/62920/3d-bioprinting-covid-19-lung-models-for-drug-development/2020-06-19T08:07:29+01:00https://drug.russellpublishing.co.uk/article/63084/what-immuno-oncology-research-can-tell-us-about-covid-19/2020-06-11T16:45:16+01:00https://drug.russellpublishing.co.uk/article/63311/why-are-women-underrepresented-in-covid-19-research-authorship/2020-06-17T16:06:23+01:00https://drug.russellpublishing.co.uk/article/63490/targeting-sarm1-to-protect-vision-across-retinal-degenerative-diseases/2020-06-23T15:37:55+01:00https://drug.russellpublishing.co.uk/article/63723/unlocking-the-power-of-machine-learning-for-small-molecule-drug-discovery/2020-06-29T11:33:22+01:00https://drug.russellpublishing.co.uk/article/63749/the-hope-of-rejuvenation-using-plasma-to-reverse-ageing-in-mice/2020-06-29T19:56:52+01:00https://drug.russellpublishing.co.uk/article/63850/the-coronavirus-seasonality-and-host-specific-action-of-a-sexy-killer/2020-06-30T14:43:41+01:00https://drug.russellpublishing.co.uk/article/63854/prophylactics-for-covid-19-known-and-unknown/2020-07-15T11:55:40+01:00https://drug.russellpublishing.co.uk/article/63859/drug-side-effects-an-open-source-tool-to-predict-adverse-reactions/2020-06-30T16:14:47+01:00https://drug.russellpublishing.co.uk/article/63902/from-inception-to-conclusion-how-digitalisation-is-impacting-drug-development/2020-07-02T13:53:53+01:00https://drug.russellpublishing.co.uk/article/65474/revealing-the-genetic-signature-of-neurodegenerative-disease/2020-07-20T15:53:03+01:00https://drug.russellpublishing.co.uk/article/65572/five-of-the-most-recent-microscopy-developments/2020-07-23T14:43:54+01:00https://drug.russellpublishing.co.uk/article/65639/five-developments-in-oncology-targets/2020-07-23T15:03:06+01:00https://drug.russellpublishing.co.uk/article/65741/a-circuit-involved-in-itching-from-skin-to-sensory-neurons/2020-07-24T16:18:45+01:00https://drug.russellpublishing.co.uk/article/67275/coronavirus-update-covid-19-vaccine-pre-clinical-developments/2020-08-04T16:27:22+01:00https://drug.russellpublishing.co.uk/article/68194/translating-novel-drug-success-in-animals-to-humans/2020-08-12T13:59:34+01:00https://drug.russellpublishing.co.uk/article/69954/innovations-for-next-generation-antibody-drug-conjugates/2020-09-03T16:53:45+01:00https://drug.russellpublishing.co.uk/article/70088/drug-target-review-issue-3-2020/2020-11-26T10:20:56+00:00https://drug.russellpublishing.co.uk/article/70101/antibodies-in-depth-focus-2020-2/2020-11-26T10:23:24+00:00https://drug.russellpublishing.co.uk/article/70104/targets-in-depth-focus-2020/2020-11-26T10:25:28+00:00https://drug.russellpublishing.co.uk/article/70212/assays-in-depth-focus-2020-2/2020-11-26T10:25:39+00:00https://drug.russellpublishing.co.uk/article/70220/ngs-in-depth-focus-2020/2020-11-26T10:26:19+00:00https://drug.russellpublishing.co.uk/article/70230/antibody-therapeutics-for-covid-19/2021-04-07T15:47:24+01:00https://drug.russellpublishing.co.uk/article/70244/defusing-antibody-neutralisers-in-aav-gene-therapy/2021-04-07T15:47:03+01:00https://drug.russellpublishing.co.uk/article/70259/oncology-meets-immunology-antibody-mediated-regulation-of-the-immune-response/2021-04-07T15:47:38+01:00https://drug.russellpublishing.co.uk/article/70400/bispecific-antibodies-the-next-generation-of-immuno-oncology-drugs/2021-04-07T15:48:47+01:00https://drug.russellpublishing.co.uk/article/70434/exploring-new-drug-targets-in-alzheimers-disease/2021-04-07T15:50:42+01:00https://drug.russellpublishing.co.uk/article/70447/novel-biomarker-technology-for-cancer-diagnostics/2021-04-07T15:50:18+01:00https://drug.russellpublishing.co.uk/article/70455/under-the-microscope-searching-for-optimised-drugs-combining-ai-with-human-expertise/2020-09-10T11:10:20+01:00https://drug.russellpublishing.co.uk/article/70464/expert-view-increasing-the-efficiency-of-biologics-development-the-secret-is-precise-and-reliable-stability-characterisation-of-candidate-molecules/2020-09-08T16:35:53+01:00https://drug.russellpublishing.co.uk/article/70482/sars-cov-2-a-spillover-from-animals-to-man-a-spillback-from-man-to-animals-and-what-next/2020-09-08T16:45:31+01:00https://drug.russellpublishing.co.uk/article/70553/expert-view-analytical-power-tool-opens-upstream-bioprocessing-bottlenecks-for-better-antibody-screening/2020-09-08T17:42:31+01:00https://drug.russellpublishing.co.uk/article/70682/advancing-cell-therapies-with-engineered-tregs/2021-04-01T15:49:37+01:00https://drug.russellpublishing.co.uk/article/70690/flow-cytometry-in-neglected-tropical-diseases-a-focus-on-leishmaniasis/2021-04-01T15:49:17+01:00https://drug.russellpublishing.co.uk/article/70702/ngs-offering-a-glimmer-of-hope-in-the-fight-against-covid-19/2021-04-07T15:49:19+01:00https://drug.russellpublishing.co.uk/article/70862/powering-forward-genomics-englands-covid-19-response/2021-04-07T15:49:05+01:00https://drug.russellpublishing.co.uk/article/70865/expert-view-why-you-should-use-3d-models-for-high-throughput-drug-development-screens/2020-09-10T16:45:25+01:00https://drug.russellpublishing.co.uk/article/70892/expert-view-ddpcr-whole-cell-dna-workflow-efficiently-measures-success-of-car-t-cell-production/2020-09-10T17:17:20+01:00https://drug.russellpublishing.co.uk/article/70912/expert-view-where-are-you-seeing-changes-in-the-flow-cytometry-market/2020-09-10T17:47:56+01:00https://drug.russellpublishing.co.uk/article/71109/expert-view-measuring-protein-interactions-in-blood-not-as-trivial-as-it-sounds/2020-12-08T11:16:08+00:00https://drug.russellpublishing.co.uk/article/71119/adding-to-the-arsenal-targeting-human-proteins-for-controlling-m-tuberculosis-growth/2021-04-07T15:50:59+01:00https://drug.russellpublishing.co.uk/article/71154/exploring-the-intra-protein-non-covalent-interactions-in-the-s1-domain-of-the-sars-cov-2-s1-spike-protein/2021-04-07T15:52:02+01:00https://drug.russellpublishing.co.uk/article/71179/covid-19-therapies-in-the-pipeline/2020-09-11T15:55:30+01:00https://drug.russellpublishing.co.uk/article/71192/under-the-microscope-transforming-drug-discovery-on-membrane-proteins/2020-09-15T09:26:17+01:00https://drug.russellpublishing.co.uk/article/71200/under-the-microscope-supporting-the-covid-19-response-with-ngs/2020-09-14T14:35:28+01:00https://drug.russellpublishing.co.uk/article/71424/understanding-the-limits-of-synthetic-biology-through-the-origins-of-sars-cov-2/2020-09-14T15:25:41+01:00https://drug.russellpublishing.co.uk/article/71619/cocaine-and-the-brain-identifying-targets-for-addiction-therapies/2020-09-15T16:16:31+01:00https://drug.russellpublishing.co.uk/article/71795/the-next-generation-of-cancer-immunotherapies-re-exploring-the-il-2-pathway/2020-09-17T14:08:38+01:00https://drug.russellpublishing.co.uk/article/72015/how-do-general-anaesthetics-cause-loss-of-consciousness/2020-09-21T17:04:38+01:00https://drug.russellpublishing.co.uk/article/72034/developing-il-15-superagonists-for-cancer-therapy/2020-09-22T13:58:47+01:00https://drug.russellpublishing.co.uk/article/74491/could-gpcrs-be-causing-people-to-respond-differently-to-the-same-drug/2020-10-16T15:30:11+01:00https://drug.russellpublishing.co.uk/article/74674/treating-cytokine-storms-in-covid-19-patients/2020-10-21T17:15:56+01:00https://drug.russellpublishing.co.uk/article/76124/developing-nanobodies-and-sybodies-to-combat-covid-19/2020-11-12T15:27:08+00:00https://drug.russellpublishing.co.uk/article/76419/acquiring-structural-data-on-membrane-proteins-a-spotlight-on-gpcrs/2020-11-17T12:28:13+00:00https://drug.russellpublishing.co.uk/article/76602/developing-an-effective-vaccine-for-breast-cancer/2020-11-20T09:16:09+00:00https://drug.russellpublishing.co.uk/article/76717/promising-targets-for-deafness-drug-discovery/2020-11-20T15:16:20+00:00https://drug.russellpublishing.co.uk/article/76907/the-latest-pre-clinical-hiv-vaccine-developments/2020-11-24T14:23:44+00:00https://drug.russellpublishing.co.uk/article/76969/crispr-a-molecular-scissor-set-to-change-the-world/2020-11-30T16:55:57+00:00https://drug.russellpublishing.co.uk/article/76994/drug-target-review-issue-4-2020/2021-03-25T11:29:34+00:00https://drug.russellpublishing.co.uk/article/76995/genetic-screening-to-predict-the-risk-of-future-diseases/2021-06-18T15:57:59+01:00https://drug.russellpublishing.co.uk/article/77001/screening-in-depth-focus-2020-2/2021-03-25T11:34:24+00:00https://drug.russellpublishing.co.uk/article/77003/upstream-bioprocessing-in-depth-focus-2020/2021-03-25T11:33:01+00:00https://drug.russellpublishing.co.uk/article/77007/covid-19-in-depth-focus-2020/2021-03-25T11:34:08+00:00https://drug.russellpublishing.co.uk/article/77107/antimicrobial-resistance-a-public-health-emergency-on-the-horizon/2021-06-18T15:58:07+01:00https://drug.russellpublishing.co.uk/article/77121/investigating-cellular-pathways-driving-severe-covid-19-with-proteomics/2021-06-18T15:59:40+01:00https://drug.russellpublishing.co.uk/article/77125/neuropilin-1-a-key-receptor-in-sars-cov-2-infection/2021-06-18T15:58:26+01:00https://drug.russellpublishing.co.uk/article/77157/development-of-a-physiologically-relevant-lung-model-for-understanding-sars-cov-2-infection/2021-06-18T15:58:41+01:00https://drug.russellpublishing.co.uk/article/77178/advancing-cho-cell-line-engineering-with-crispr/2021-06-18T15:55:56+01:00https://drug.russellpublishing.co.uk/article/77204/biosynthetic-polysaccharide-based-drugs-and-nutraceuticals-from-non-animal-sources/2021-06-18T15:57:08+01:00https://drug.russellpublishing.co.uk/article/77318/label-free-imaging-technique-drug-evaluation-single-cell-level/2021-03-18T15:16:59+00:00https://drug.russellpublishing.co.uk/article/77331/tracking-sars-cov-2-with-genome-sequencing/2021-06-18T15:56:26+01:00https://drug.russellpublishing.co.uk/article/77332/predicting-covid-19-susceptibility-and-severity/2020-11-30T16:48:39+00:00https://drug.russellpublishing.co.uk/article/77377/precision-medicine-beyond-oncology/2020-11-30T16:47:26+00:00https://drug.russellpublishing.co.uk/article/77513/tweaking-synonymous-sites-for-gene-therapy-and-vaccines/2020-11-30T15:16:40+00:00https://drug.russellpublishing.co.uk/article/77531/a-rational-approach-to-discover-and-precision-engineer-new-biologic-drugs/2020-11-30T16:48:58+00:00https://drug.russellpublishing.co.uk/article/77680/a-novel-blood-brain-barrier-model-for-cerebral-malaria-research/2020-12-01T16:40:38+00:00https://drug.russellpublishing.co.uk/article/77687/combining-deep-computational-learning-and-synthetic-biology/2020-12-03T16:24:00+00:00https://drug.russellpublishing.co.uk/article/78092/trends-in-pancreatic-cancer-literature-findings-from-elsevier/2020-12-09T16:50:29+00:00https://drug.russellpublishing.co.uk/article/78245/the-editors-views-drug-target-reviews-2020-round-up/2020-12-14T09:58:42+00:00https://drug.russellpublishing.co.uk/article/78484/human-3d-cell-based-systems-to-research-gout-drug-discovery-for-a-neglected-disease/2020-12-18T16:05:45+00:00https://drug.russellpublishing.co.uk/article/78581/rna-sequencing-provides-insights-into-why-every-sars-cov-2-infection-is-different/2020-12-16T11:28:30+00:00https://drug.russellpublishing.co.uk/article/78715/a-computational-effort-to-deciphering-putative-covid-19-3c-like-protease-binders/2020-12-17T18:55:20+00:00https://drug.russellpublishing.co.uk/article/78724/covid-19-drug-development-based-on-boosting-immunity/2020-12-17T19:03:55+00:00https://drug.russellpublishing.co.uk/article/78726/unlocking-the-power-of-the-microbiome-in-life-sciences-rd/2020-12-17T19:36:50+00:00https://drug.russellpublishing.co.uk/article/79054/how-data-science-is-driving-genomics-in-the-pharmaceutical-industry/2021-01-05T15:12:18+00:00https://drug.russellpublishing.co.uk/article/79343/a-single-approach-to-creating-effective-cancer-and-autoimmune-disease-therapeutics/2021-01-07T16:26:25+00:00https://drug.russellpublishing.co.uk/article/80737/crispr-three-new-developments-in-the-world-of-gene-editing/2021-01-13T17:01:09+00:00https://drug.russellpublishing.co.uk/article/81156/a-novel-car-t-cell-therapy-to-treat-lymphomas/2021-01-20T14:56:42+00:00https://drug.russellpublishing.co.uk/article/81258/what-is-new-in-the-world-of-imaging/2021-01-21T14:57:24+00:00https://drug.russellpublishing.co.uk/article/81483/artificial-intelligence-advancing-drug-discovery-the-future-is-multi-cellular-studies/2021-04-19T13:45:54+01:00https://drug.russellpublishing.co.uk/article/82072/preventing-stem-cells-from-transforming-into-pre-leukaemia-stem-cells/2021-02-01T13:51:31+00:00https://drug.russellpublishing.co.uk/article/82447/could-metabo-oncology-be-the-treatment-modality-of-the-future/2021-02-03T14:40:12+00:00https://drug.russellpublishing.co.uk/article/82496/sars-cov-2-and-immunology-antibody-developments/2021-02-03T18:46:19+00:00https://drug.russellpublishing.co.uk/article/82588/could-downregulating-the-drp1-protein-prevent-alzheimers-progression/2021-02-04T14:52:58+00:00https://drug.russellpublishing.co.uk/article/83808/advancing-neutralising-antibody-therapies-for-covid-19/2021-06-10T10:04:31+01:00https://drug.russellpublishing.co.uk/article/83945/high-throughput-laboratory-evolution-reveals-how-bacteria-gain-drug-resistance/2021-02-18T15:06:34+00:00https://drug.russellpublishing.co.uk/article/84050/nox5-a-novel-target-for-sensitising-melanoma-to-therapies/2021-02-19T16:01:23+00:00https://drug.russellpublishing.co.uk/article/85317/developing-bioenergetic-nanocatalysts-a-novel-approach-to-treat-neurodegeneration/2021-03-08T13:54:59+00:00https://drug.russellpublishing.co.uk/article/85765/what-we-know-about-covid-19-and-the-inflammatory-response/2021-03-10T11:42:21+00:00https://drug.russellpublishing.co.uk/article/86433/a-strategy-to-cloak-gene-therapy-aav-vectors-from-immune-responses/2021-03-17T18:29:13+00:00https://drug.russellpublishing.co.uk/article/86438/sars-cov-2-variants-the-role-of-sequencing-and-vaccine-development/2021-03-17T18:41:26+00:00https://drug.russellpublishing.co.uk/article/87098/covid-19-in-europe-one-year-on-from-the-first-case/2021-03-29T14:47:04+01:00https://drug.russellpublishing.co.uk/article/87106/drug-target-review-issue-1-2021/2021-06-14T13:54:59+01:00https://drug.russellpublishing.co.uk/article/87112/assays-in-depth-focus-2021/2021-06-14T13:55:32+01:00https://drug.russellpublishing.co.uk/article/87118/antibodies-in-depth-focus-2021/2021-06-14T13:55:42+01:00https://drug.russellpublishing.co.uk/article/87122/vaccine-development-in-depth-focus-2021/2021-06-14T13:55:57+01:00https://drug.russellpublishing.co.uk/article/87135/expanding-accessible-chemical-space-through-automated-high-throughput-experimentation/2021-06-04T16:02:12+01:00https://drug.russellpublishing.co.uk/article/87154/synthesising-very-long-chain-fatty-acids-to-treat-retinal-conditions/2021-06-04T16:02:45+01:00https://drug.russellpublishing.co.uk/article/87178/covid-19-drug-targets-and-cell-based-assays/2021-03-30T17:02:38+01:00https://drug.russellpublishing.co.uk/article/87191/a-novel-assay-to-reveal-cyclic-peptides-with-affinity-to-ubiquitin/2021-03-31T10:29:09+01:00https://drug.russellpublishing.co.uk/article/87283/developing-a-broadly-neutralising-antibody-therapeutic-to-combat-sars-cov-2/2021-03-31T17:18:18+01:00https://drug.russellpublishing.co.uk/article/87307/fighting-hiv-could-antibodies-be-the-answer/2021-04-01T13:08:40+01:00https://drug.russellpublishing.co.uk/article/87322/the-development-of-biomaterial-based-vaccine-platforms-against-viruses/2021-03-31T17:09:13+01:00https://drug.russellpublishing.co.uk/article/87357/broad-t-cell-responses-designing-a-rhinovirus-vaccine/2021-03-31T15:02:11+01:00https://drug.russellpublishing.co.uk/article/87433/which-cho-cell-is-the-right-cho-cell/2021-06-04T16:32:36+01:00https://drug.russellpublishing.co.uk/article/87456/immunosurveillance-and-the-importance-of-cd4-t-cells-in-developing-cancer-vaccines/2021-04-01T08:26:33+01:00https://drug.russellpublishing.co.uk/article/87457/identifying-a-novel-treatment-for-heart-attacks/2021-03-29T11:57:17+01:00https://drug.russellpublishing.co.uk/article/88080/glycolytic-pathway-inhibition-and-ctla-4-blockade-to-improve-immuno-oncology/2021-04-01T08:45:37+01:00https://drug.russellpublishing.co.uk/article/88241/how-rna-therapeutics-can-be-used-to-treat-retinitis-pigmentosa/2021-08-23T12:12:32+01:00https://drug.russellpublishing.co.uk/article/88831/covid-19-broad-spectrum-therapeutics-and-the-magic-blanket-paradigm/2021-04-19T13:58:52+01:00https://drug.russellpublishing.co.uk/article/89340/exploring-the-connection-between-covid-19-and-diabetes/2021-04-16T11:30:30+01:00https://drug.russellpublishing.co.uk/article/89438/targeting-tnf-to-treat-dupuytrens-disease-frozen-shoulder-and-pocd/2021-04-22T13:54:50+01:00https://drug.russellpublishing.co.uk/article/90067/protecting-liposomes-in-covid-19-mrna-vaccines-could-increase-their-stability/2021-04-27T16:44:30+01:00https://drug.russellpublishing.co.uk/article/90328/ebook-antibody-discovery-technology-and-techniques-to-boost-development/2021-05-26T09:33:32+01:00https://drug.russellpublishing.co.uk/article/90375/new-developments-in-the-research-field-of-immuno-oncology/2021-04-30T15:25:11+01:00https://drug.russellpublishing.co.uk/article/90804/airway-on-a-chip-technology-enables-covid-19-drug-repurposing/2021-05-07T14:00:26+01:00https://drug.russellpublishing.co.uk/article/91083/healthcare-demands-drive-domestic-uk-biotech-investment/2021-05-10T15:57:53+01:00https://drug.russellpublishing.co.uk/article/91312/five-of-the-latest-developments-in-3d-bioprinting/2021-05-13T10:39:49+01:00https://drug.russellpublishing.co.uk/article/91542/how-microfluidics-can-automate-drug-discovery-and-development/2021-05-17T14:42:56+01:00https://drug.russellpublishing.co.uk/article/91663/millennia-in-the-making-unlocking-the-medicinal-value-of-cbd/2021-05-19T18:57:06+01:00https://drug.russellpublishing.co.uk/article/91858/monitoring-the-potency-of-cell-therapies-using-bioelectronic-assays/2021-05-24T14:04:53+01:00https://drug.russellpublishing.co.uk/article/92497/ai-informatics-drug-discovery/2021-09-29T19:50:52+01:00https://drug.russellpublishing.co.uk/article/92596/challenges-and-opportunities-in-gene-therapy-development/2021-06-15T18:18:10+01:00https://drug.russellpublishing.co.uk/article/92688/drug-target-review-issue-2-2021/2021-09-22T07:42:41+01:00https://drug.russellpublishing.co.uk/article/92702/off-the-shelf-t-cell-therapy-from-gene-edited-stem-cells/2021-06-09T17:05:33+01:00https://drug.russellpublishing.co.uk/article/92792/drug-target-review-antibodies-ebook-2021/2021-09-22T07:43:11+01:00https://drug.russellpublishing.co.uk/article/92799/drug-target-review-screening-ebook-2021/2021-09-22T07:43:47+01:00https://drug.russellpublishing.co.uk/article/92806/drug-target-review-cell-gene-therapy-ebook-2021/2021-09-22T07:43:31+01:00https://drug.russellpublishing.co.uk/article/92821/drug-target-review-stem-cells-ebook-2021/2021-09-22T07:44:01+01:00https://drug.russellpublishing.co.uk/article/92878/the-potential-of-epigenomic-medicine-in-cardiology/2021-06-22T10:20:49+01:00https://drug.russellpublishing.co.uk/article/92896/using-cholangiocyte-organoids-to-regenerate-human-bile-ducts/2021-06-22T17:04:13+01:00https://drug.russellpublishing.co.uk/article/92946/the-other-end-of-the-antibody-fc-biology-and-immunotherapy/2021-06-14T15:25:45+01:00https://drug.russellpublishing.co.uk/article/93060/making-cell-culture-models-more-physiologically-relevant/2021-06-30T13:44:28+01:00https://drug.russellpublishing.co.uk/article/93063/novel-vectors-for-more-efficient-and-less-risky-ocular-gene-therapy/2021-06-22T17:07:40+01:00https://drug.russellpublishing.co.uk/article/93076/how-to-mix-the-best-anti-sars-cov-2-cocktail/2021-08-18T09:58:21+01:00https://drug.russellpublishing.co.uk/article/93092/better-therapeutic-antibodies-by-design/2021-06-22T17:03:21+01:00https://drug.russellpublishing.co.uk/article/93100/why-some-screening-hits-are-a-pain/2021-09-09T16:03:24+01:00https://drug.russellpublishing.co.uk/article/93111/assessing-compound-activity-to-accelerate-drug-discovery/2021-06-22T11:18:19+01:00https://drug.russellpublishing.co.uk/article/93155/drug-development-in-stem-cell-derived-liver-organoid-models/2021-06-23T16:38:00+01:00https://drug.russellpublishing.co.uk/article/93172/transcriptional-reprogramming-rescues-vascular-fate-of-misidentified-pluripotent-cell%e2%80%91derived-epithelial-cells/2021-07-01T14:45:36+01:00https://drug.russellpublishing.co.uk/article/93312/screening-for-covid-19-drugs/2021-06-22T11:26:30+01:00https://drug.russellpublishing.co.uk/article/93327/targeting-phosphodiesterase-3a-discovery-of-a-promising-cancer-therapy/2021-06-22T11:35:31+01:00https://drug.russellpublishing.co.uk/article/93346/covalent-fragment-screening-in-cell-based-phenotypic-models-of-disease-a-collaborative-approach/2021-06-22T11:40:15+01:00https://drug.russellpublishing.co.uk/article/93366/the-use-of-biophysical-methods-in-the-hit-to-lead-process/2021-08-25T12:21:46+01:00https://drug.russellpublishing.co.uk/article/93378/the-benefits-of-lab-automation-in-life-sciences/2021-06-22T10:33:57+01:00https://drug.russellpublishing.co.uk/article/93388/digital-revolution-not-evolution-is-the-route-to-building-back-stronger-after-covid-19/2021-06-21T10:07:51+01:00https://drug.russellpublishing.co.uk/article/93561/under-the-microscope-exploring-phage-display-technologies-for-drug-discovery-and-early-development/2021-06-21T13:40:22+01:00https://drug.russellpublishing.co.uk/article/94284/why-the-system-for-biospecimen-procurement-is-broken/2021-07-05T12:36:00+01:00https://drug.russellpublishing.co.uk/article/94532/how-engineered-rna-binding-proteins-delivered-in-vivo-by-gene-therapy-could-treat-myotonic-dystrophy/2021-07-13T12:03:34+01:00https://drug.russellpublishing.co.uk/article/94642/recognition-of-phosphohistidine-containing-peptides-by-antibodies/2021-07-28T13:32:01+01:00https://drug.russellpublishing.co.uk/article/94853/lentiviral-vectors-the-key-to-cancer-treatments-that-car-t-cell-therapy-cannot-reach/2021-08-23T09:30:53+01:00https://drug.russellpublishing.co.uk/article/95502/new-models-for-intranasal-drug-delivery/2021-08-06T09:30:54+01:00https://drug.russellpublishing.co.uk/article/95611/spatial-genomic-and-transcriptomic-imaging-in-drug-discovery/2021-08-10T10:21:28+01:00https://drug.russellpublishing.co.uk/article/95690/noisy-gene-expression-may-help-improve-stem-cell-therapies/2021-08-17T09:30:30+01:00https://drug.russellpublishing.co.uk/article/95958/getting-under-the-skin-of-frontotemporal-dementia/2021-09-10T09:00:57+01:00https://drug.russellpublishing.co.uk/article/96311/delivering-gene-therapies-to-the-brain-to-treat-alzheimers/2021-09-10T09:00:51+01:00https://drug.russellpublishing.co.uk/article/96381/sample-preparation-automation-in-label-free-compound-profiling/2021-08-31T21:35:41+01:00https://drug.russellpublishing.co.uk/article/96688/accelerating-drug-discovery-with-disruptive-computational-methods/2021-09-23T15:36:05+01:00https://drug.russellpublishing.co.uk/article/96694/telomerase-a-universal-cancer-target-for-immunotherapeutic-vaccines/2023-11-27T12:55:45+00:00https://drug.russellpublishing.co.uk/article/96726/drug-target-review-issue-3-2021/2021-09-22T07:55:17+01:00https://drug.russellpublishing.co.uk/article/96732/drug-target-review-vaccine-development-ebook-2021/2021-09-22T08:03:48+01:00https://drug.russellpublishing.co.uk/article/96742/drug-target-review-synthetic-biology-ebook-2021/2021-10-06T10:54:14+01:00https://drug.russellpublishing.co.uk/article/96753/drug-target-review-antibodies-ebook-2021-2/2021-09-22T18:36:47+01:00https://drug.russellpublishing.co.uk/article/96756/drug-target-review-assays-ebook-2021/2021-09-22T18:47:32+01:00https://drug.russellpublishing.co.uk/article/96925/an-integrated-vaccination-approach-to-neurodegeneration/2021-10-08T10:46:21+01:00https://drug.russellpublishing.co.uk/article/96956/using-brain-models-of-patient-specific-alzheimers-insights/2021-09-23T15:17:01+01:00https://drug.russellpublishing.co.uk/article/96994/crispr-cas9-based-gene-dropout-screens-a-powerful-platform-for-drug-discovery/2021-09-29T09:33:25+01:00https://drug.russellpublishing.co.uk/article/97051/the-diversity-of-synthetic-biology-applications/2021-12-10T08:44:07+00:00https://drug.russellpublishing.co.uk/article/97066/high-throughput-3d-cell-migration-assays-in-organ-on-a-chip-technologies/2022-01-18T11:14:36+00:00https://drug.russellpublishing.co.uk/article/97080/investigating-neural-oscillations-in-human-brain-organoids/2021-09-21T09:42:48+01:00https://drug.russellpublishing.co.uk/article/97100/why-there-is-a-blockage-in-the-biosample-system/2022-01-12T09:21:09+00:00https://drug.russellpublishing.co.uk/article/97106/an-igm-antibody-platform-to-tackle-sars-cov-2-and-its-variants/2021-09-23T18:23:43+01:00https://drug.russellpublishing.co.uk/article/97220/under-the-microscope-leveraging-crispr-libraries-for-target-discovery/2021-09-22T19:28:41+01:00https://drug.russellpublishing.co.uk/article/97333/determining-the-structure-of-nanobodies-using-nuclear-magnetic-resonance-spectroscopy/2021-09-30T09:50:46+01:00https://drug.russellpublishing.co.uk/article/97460/targeting-sars-cov-2-replication-with-inhibitors-of-lipid-metabolism/2021-09-30T12:01:45+01:00https://drug.russellpublishing.co.uk/article/97469/improving-drug-discovery-with-advanced-targeted-proteomic-monitoring-workflows/2021-12-21T14:39:04+00:00https://drug.russellpublishing.co.uk/article/97678/targeting-disease-pathways-to-treat-ulcerative-colitis-beyond-corticosteroid-use/2021-09-29T09:32:17+01:00https://drug.russellpublishing.co.uk/article/97808/ai-informatics-drug-discovery-and-development-industry-survey-infographic/2022-01-18T11:10:44+00:00https://drug.russellpublishing.co.uk/article/98366/are-computer-simulations-the-future-of-rapid-covid-19-drug-development/2022-02-01T11:39:35+00:00https://drug.russellpublishing.co.uk/article/98779/peptides-a-promising-alternative-to-opioids-for-chronic-pain-relief/2022-09-20T08:59:05+01:00https://drug.russellpublishing.co.uk/article/98965/human-ipsc-derived-cardiomyocytes-for-cardiac-proarrhythmic-risk-assessment/2022-09-20T08:56:58+01:00https://drug.russellpublishing.co.uk/article/99407/test/2023-06-15T07:52:53+01:00https://drug.russellpublishing.co.uk/article/119671/test-post-27-02-26/2026-02-27T15:38:32+00:00